<?xml-model href="../../../core/DECOR.sch" type="application/xml" schematypens="http://purl.oclc.org/dsdl/schematron"?><?xml-stylesheet type="text/xsl" href="https://assets.art-decor.org/ADAR/rv/DECOR2schematron.xsl"?>
<decor xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="https://assets.art-decor.org/ADAR/rv/DECOR.xsd">
    <project id="2.16.840.1.113883.3.1937.99.60.14" prefix="demo14-" experimental="true" defaultLanguage="en-US">
        <name language="en-US" lastTranslated="2025-04-04T13:17:10">Demo 14: Mappings RXNorm and CVx to SNOMED-CT</name>
        <desc language="en-US" lastTranslated="2025-04-04T13:17:10"><p>This is a demo project with examples of</p><p><strong>RxNorm and CVx Value Sets, SNOMED-CT Value Sets </strong>and <strong>Concept Maps</strong>, namely</p><ul><li><p>accociated maps between CVx Vaccination Codes and SNOMED-CT Vaccine Product Codes.</p></li></ul><p><strong>RxNorm</strong></p><p>This project uses publicly
                available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.</p><p><strong>CVx</strong></p><p>This project uses vaccine‐administered (CVX) codes maintained by the U.S. Centers for Disease Control and
                Prevention (CDC), National Center for Immunization and Respiratory Diseases. The CDC makes no endorsement of this product, and the codes are provided “as‐is” for immunization data exchange.</p><p><strong>SNOMED-CT</strong></p><p>This project includes content from SNOMED Clinical Terms® (SNOMED CT®) which is copyright of the International Health Terminology Standards Development
                Organisation (IHTSDO). Implementers of these specifications must have the appropriate SNOMED CT Affiliate license - for more information contact http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org</p></desc>
        <copyright years="2025-" by="The ART-DECOR Expert Group" logo="art-decor-logo2.png" type="author">
            <addrLine>The ART-DECOR Expert Group</addrLine>
            <addrLine type="email">info@art-decor.org</addrLine>
            <addrLine type="email">contact@art-decor.org</addrLine>
            <addrLine type="uri">https://art-decor.org</addrLine>
            <addrLine type="linkedin">https://www.linkedin.com/company/art-decor-org</addrLine>
            <addrLine type="twitter">https://twitter.com/artdecortool</addrLine>
        </copyright>
        <copyright years="2025-" by="ART-DECOR Open Tools GmbH" logo="art-decor-open-tools.jpg" type="reviewer">
            <addrLine>ART-DECOR Open Tools GmbH</addrLine>
            <addrLine type="email">info@art-decor-open-tools.net</addrLine>
            <addrLine type="uri">https://art-decor-open-tools.net</addrLine>
            <addrLine type="linkedin">https://www.linkedin.com/company/art-decor-open-tools</addrLine>
        </copyright>
        <author id="1" username="admin" notifier="off">Admin</author>
        <author id="2" username="kai" email="info@kheitmann.de" notifier="on" effectiveDate="2025-03-27T19:06:39">dr Kai Heitmann</author>
        <reference url="https://examples.art-decor.pub/demo14/"/>
        <restURI for="FHIR" format="4.0">http://localhost:8877/exist/apps/fhir/4.0/</restURI>
        <version date="2025-04-26T13:17:10" by="kai">
            <desc language="en-US">Project created</desc>
        </version>
    </project>
    <datasets>
        <dataset id="2.16.840.1.113883.3.1937.99.60.14.1.1" effectiveDate="2025-04-04T13:17:10" statusCode="draft">
            <name language="en-US">??</name>
            <desc language="en-US">??</desc>
            <concept id="2.16.840.1.113883.3.1937.99.60.14.2.1.1" effectiveDate="2025-04-04T13:17:10" type="item" statusCode="draft">
                <name language="en-US">??</name>
                <desc language="en-US">??</desc>
                <valueDomain type="string"/>
            </concept>
        </dataset>
    </datasets>
    <scenarios>
        <actors/>
    </scenarios>
    <ids>
        <baseId id="2.16.840.1.113883.3.1937.99.60.14.1" type="DS" prefix="demo14-dataset-"/>
        <baseId id="2.16.840.1.113883.3.1937.99.60.14.2.1" type="DE" prefix="demo14-dataelement-"/>
        <baseId id="2.16.840.1.113883.3.1937.99.60.14.3" type="SC" prefix="demo14-scenario-"/>
        <baseId id="2.16.840.1.113883.3.1937.99.60.14.4" type="TR" prefix="demo14-transaction-"/>
        <baseId id="2.16.840.1.113883.3.1937.99.60.14.5" type="CS" prefix="demo14-codesystem-"/>
        <baseId id="2.16.840.1.113883.3.1937.99.60.14.6" type="IS" prefix="demo14-issue-"/>
        <baseId id="2.16.840.1.113883.3.1937.99.60.14.7" type="AC" prefix="demo14-actor-"/>
        <baseId id="2.16.840.1.113883.3.1937.99.60.14.8" type="CL" prefix="demo14-conceptlist-"/>
        <baseId id="2.16.840.1.113883.3.1937.99.60.14.9" type="EL" prefix="demo14-template-element-"/>
        <baseId id="2.16.840.1.113883.3.1937.99.60.14.10" type="TM" prefix="demo14-template-"/>
        <baseId id="2.16.840.1.113883.3.1937.99.60.14.11" type="VS" prefix="demo14-valueset-"/>
        <baseId id="2.16.840.1.113883.3.1937.99.60.14.16" type="RL" prefix="demo14-rule-intern-"/>
        <baseId id="2.16.840.1.113883.3.1937.99.60.14.18" type="SX" prefix="demo14-test-scenario-"/>
        <baseId id="2.16.840.1.113883.3.1937.99.60.14.19" type="EX" prefix="demo14-example-instance-"/>
        <baseId id="2.16.840.1.113883.3.1937.99.60.14.20" type="QX" prefix="demo14-qualification-test-instance-"/>
        <baseId id="2.16.840.1.113883.3.1937.99.60.14.21" type="CM" prefix="demo14-community-"/>
        <baseId id="2.16.840.1.113883.3.1937.99.60.14.22" type="TX" prefix="demo14-test-dataelement-"/>
        <baseId id="2.16.840.1.113883.3.1937.99.60.14.24" type="MP" prefix="demo14-map-"/>
        <baseId id="2.16.840.1.113883.3.1937.99.60.14.26" type="SD" prefix="demo14-structuredefinition-"/>
        <baseId id="2.16.840.1.113883.3.1937.99.60.14.27" type="QQ" prefix="demo14-questionnaire-"/>
        <baseId id="2.16.840.1.113883.3.1937.99.60.14.28" type="QR" prefix="demo14-questionnaire-response-"/>
        <baseId id="2.16.840.1.113883.3.1937.99.60.14.29" type="IG" prefix="demo14-implementationguide-"/>
        <defaultBaseId id="2.16.840.1.113883.3.1937.99.60.14.1" type="DS"/>
        <defaultBaseId id="2.16.840.1.113883.3.1937.99.60.14.2.1" type="DE"/>
        <defaultBaseId id="2.16.840.1.113883.3.1937.99.60.14.3" type="SC"/>
        <defaultBaseId id="2.16.840.1.113883.3.1937.99.60.14.4" type="TR"/>
        <defaultBaseId id="2.16.840.1.113883.3.1937.99.60.14.5" type="CS"/>
        <defaultBaseId id="2.16.840.1.113883.3.1937.99.60.14.6" type="IS"/>
        <defaultBaseId id="2.16.840.1.113883.3.1937.99.60.14.7" type="AC"/>
        <defaultBaseId id="2.16.840.1.113883.3.1937.99.60.14.8" type="CL"/>
        <defaultBaseId id="2.16.840.1.113883.3.1937.99.60.14.9" type="EL"/>
        <defaultBaseId id="2.16.840.1.113883.3.1937.99.60.14.10" type="TM"/>
        <defaultBaseId id="2.16.840.1.113883.3.1937.99.60.14.11" type="VS"/>
        <defaultBaseId id="2.16.840.1.113883.3.1937.99.60.14.16" type="RL"/>
        <defaultBaseId id="2.16.840.1.113883.3.1937.99.60.14.18" type="SX"/>
        <defaultBaseId id="2.16.840.1.113883.3.1937.99.60.14.19" type="EX"/>
        <defaultBaseId id="2.16.840.1.113883.3.1937.99.60.14.20" type="QX"/>
        <defaultBaseId id="2.16.840.1.113883.3.1937.99.60.14.21" type="CM"/>
        <defaultBaseId id="2.16.840.1.113883.3.1937.99.60.14.22" type="TX"/>
        <defaultBaseId id="2.16.840.1.113883.3.1937.99.60.14.24" type="MP"/>
        <defaultBaseId id="2.16.840.1.113883.3.1937.99.60.14.26" type="SD"/>
        <defaultBaseId id="2.16.840.1.113883.3.1937.99.60.14.27" type="QQ"/>
        <defaultBaseId id="2.16.840.1.113883.3.1937.99.60.14.28" type="QR"/>
        <defaultBaseId id="2.16.840.1.113883.3.1937.99.60.14.29" type="IG"/>
    </ids>
    <terminology>
        <valueSet id="2.16.840.1.113883.3.1937.99.60.14.11.1" name="CVx1" displayName="Vaccine Administered Code Set (CVX)" effectiveDate="2025-04-26T00:00:00" statusCode="draft">
            <desc language="en-US" lastTranslated="2025-04-04T13:23:33">
                <p>Vaccine Administered Code Set (CVX) System: http://hl7.org/fhir/sid/cvx</p>
                <p style="color: orange">For testing and demo puposes only</p>
            </desc>
            <conceptList>
                <concept code="1" codeSystem="2.16.840.1.113883.12.292" displayName="diphtheria, tetanus toxoids and pertussis vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="DTP"/>
                </concept>
                <concept code="2" codeSystem="2.16.840.1.113883.12.292" displayName="trivalent poliovirus vaccine, live, oral" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="OPV"/>
                </concept>
                <concept code="3" codeSystem="2.16.840.1.113883.12.292" displayName="measles, mumps and rubella virus vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="MMR"/>
                </concept>
                <concept code="4" codeSystem="2.16.840.1.113883.12.292" displayName="measles and rubella virus vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="M/R"/>
                </concept>
                <concept code="5" codeSystem="2.16.840.1.113883.12.292" displayName="measles virus vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="measles"/>
                </concept>
                <concept code="6" codeSystem="2.16.840.1.113883.12.292" displayName="rubella virus vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="rubella"/>
                </concept>
                <concept code="7" codeSystem="2.16.840.1.113883.12.292" displayName="mumps virus vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="mumps"/>
                </concept>
                <concept code="8" codeSystem="2.16.840.1.113883.12.292" displayName="hepatitis B vaccine, pediatric or pediatric/adolescent dosage" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hep B, adolescent or pediatric"/>
                </concept>
                <concept code="9" codeSystem="2.16.840.1.113883.12.292" displayName="tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed"/>
                </concept>
                <concept code="10" codeSystem="2.16.840.1.113883.12.292" displayName="poliovirus vaccine, inactivated" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="IPV"/>
                </concept>
                <concept code="11" codeSystem="2.16.840.1.113883.12.292" displayName="pertussis vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="pertussis"/>
                </concept>
                <concept code="12" codeSystem="2.16.840.1.113883.12.292" displayName="diphtheria antitoxin" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="diphtheria antitoxin"/>
                </concept>
                <concept code="13" codeSystem="2.16.840.1.113883.12.292" displayName="tetanus immune globulin" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="TIG"/>
                </concept>
                <concept code="14" codeSystem="2.16.840.1.113883.12.292" displayName="immune globulin, unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="IG, unspecified formulation"/>
                </concept>
                <concept code="15" codeSystem="2.16.840.1.113883.12.292" displayName="influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="influenza, split (incl. purified surface antigen)"/>
                </concept>
                <concept code="16" codeSystem="2.16.840.1.113883.12.292" displayName="influenza virus vaccine, whole virus" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="influenza, whole"/>
                </concept>
                <concept code="17" codeSystem="2.16.840.1.113883.12.292" displayName="Haemophilus influenzae type b vaccine, conjugate unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hib, unspecified formulation"/>
                </concept>
                <concept code="18" codeSystem="2.16.840.1.113883.12.292" displayName="rabies vaccine, for intramuscular injection RETIRED CODE" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="rabies, intramuscular injection"/>
                </concept>
                <concept code="19" codeSystem="2.16.840.1.113883.12.292" displayName="Bacillus Calmette-Guerin vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="BCG"/>
                </concept>
                <concept code="20" codeSystem="2.16.840.1.113883.12.292" displayName="diphtheria, tetanus toxoids and acellular pertussis vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="DTaP"/>
                </concept>
                <concept code="21" codeSystem="2.16.840.1.113883.12.292" displayName="varicella virus vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="varicella"/>
                </concept>
                <concept code="22" codeSystem="2.16.840.1.113883.12.292" displayName="DTP-Haemophilus influenzae type b conjugate vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="DTP-Hib"/>
                </concept>
                <concept code="23" codeSystem="2.16.840.1.113883.12.292" displayName="plague vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="plague"/>
                </concept>
                <concept code="24" codeSystem="2.16.840.1.113883.12.292" displayName="anthrax vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="anthrax"/>
                </concept>
                <concept code="25" codeSystem="2.16.840.1.113883.12.292" displayName="typhoid vaccine, live, oral" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="typhoid, oral"/>
                </concept>
                <concept code="26" codeSystem="2.16.840.1.113883.12.292" displayName="cholera vaccine, unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="cholera, unspecified formulation"/>
                </concept>
                <concept code="27" codeSystem="2.16.840.1.113883.12.292" displayName="botulinum antitoxin" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="botulinum antitoxin"/>
                </concept>
                <concept code="28" codeSystem="2.16.840.1.113883.12.292" displayName="diphtheria and tetanus toxoids, adsorbed for pediatric use" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="DT (pediatric)"/>
                </concept>
                <concept code="29" codeSystem="2.16.840.1.113883.12.292" displayName="cytomegalovirus immune globulin, intravenous" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="CMVIG"/>
                </concept>
                <concept code="30" codeSystem="2.16.840.1.113883.12.292" displayName="hepatitis B immune globulin" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="HBIG"/>
                </concept>
                <concept code="31" codeSystem="2.16.840.1.113883.12.292" displayName="hepatitis A vaccine, pediatric dosage, unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hep A, pediatric, unspecified formulation"/>
                </concept>
                <concept code="32" codeSystem="2.16.840.1.113883.12.292" displayName="meningococcal polysaccharide vaccine (MPSV4)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="meningococcal MPSV4"/>
                </concept>
                <concept code="33" codeSystem="2.16.840.1.113883.12.292" displayName="pneumococcal polysaccharide vaccine, 23 valent" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="pneumococcal polysaccharide PPV23"/>
                </concept>
                <concept code="34" codeSystem="2.16.840.1.113883.12.292" displayName="rabies immune globulin" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="RIG"/>
                </concept>
                <concept code="35" codeSystem="2.16.840.1.113883.12.292" displayName="tetanus toxoid, adsorbed" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="tetanus toxoid, adsorbed"/>
                </concept>
                <concept code="36" codeSystem="2.16.840.1.113883.12.292" displayName="varicella zoster immune globulin" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="VZIG"/>
                </concept>
                <concept code="37" codeSystem="2.16.840.1.113883.12.292" displayName="yellow fever vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="yellow fever"/>
                </concept>
                <concept code="38" codeSystem="2.16.840.1.113883.12.292" displayName="rubella and mumps virus vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="rubella/mumps"/>
                </concept>
                <concept code="39" codeSystem="2.16.840.1.113883.12.292" displayName="Japanese Encephalitis Vaccine SC" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Japanese encephalitis SC"/>
                </concept>
                <concept code="40" codeSystem="2.16.840.1.113883.12.292" displayName="rabies vaccine, for intradermal injection" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="rabies, intradermal injection"/>
                </concept>
                <concept code="41" codeSystem="2.16.840.1.113883.12.292" displayName="typhoid vaccine, parenteral, other than acetone-killed, dried" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="typhoid, parenteral"/>
                </concept>
                <concept code="42" codeSystem="2.16.840.1.113883.12.292" displayName="hepatitis B vaccine, adolescent/high risk infant dosage" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hep B, adolescent/high risk infant"/>
                </concept>
                <concept code="43" codeSystem="2.16.840.1.113883.12.292" displayName="hepatitis B vaccine, adult dosage" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hep B, adult"/>
                </concept>
                <concept code="44" codeSystem="2.16.840.1.113883.12.292" displayName="hepatitis B vaccine, dialysis patient dosage" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hep B, dialysis"/>
                </concept>
                <concept code="45" codeSystem="2.16.840.1.113883.12.292" displayName="hepatitis B vaccine, unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hep B, unspecified formulation"/>
                </concept>
                <concept code="46" codeSystem="2.16.840.1.113883.12.292" displayName="Haemophilus influenzae type b vaccine, PRP-D conjugate" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hib (PRP-D)"/>
                </concept>
                <concept code="47" codeSystem="2.16.840.1.113883.12.292" displayName="Haemophilus influenzae type b vaccine, HbOC conjugate" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hib (HbOC)"/>
                </concept>
                <concept code="48" codeSystem="2.16.840.1.113883.12.292" displayName="Haemophilus influenzae type b vaccine, PRP-T conjugate" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hib (PRP-T)"/>
                </concept>
                <concept code="49" codeSystem="2.16.840.1.113883.12.292" displayName="Haemophilus influenzae type b vaccine, PRP-OMP conjugate" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hib (PRP-OMP)"/>
                </concept>
                <concept code="50" codeSystem="2.16.840.1.113883.12.292" displayName="DTaP-Haemophilus influenzae type b conjugate vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="DTaP-Hib"/>
                </concept>
                <concept code="51" codeSystem="2.16.840.1.113883.12.292" displayName="Haemophilus influenzae type b conjugate and Hepatitis B vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hib-Hep B"/>
                </concept>
                <concept code="52" codeSystem="2.16.840.1.113883.12.292" displayName="hepatitis A vaccine, adult dosage" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hep A, adult"/>
                </concept>
                <concept code="53" codeSystem="2.16.840.1.113883.12.292" displayName="typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="typhoid, parenteral, AKD (U.S. military)"/>
                </concept>
                <concept code="54" codeSystem="2.16.840.1.113883.12.292" displayName="adenovirus vaccine, type 4, live, oral" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="adenovirus, type 4"/>
                </concept>
                <concept code="55" codeSystem="2.16.840.1.113883.12.292" displayName="adenovirus vaccine, type 7, live, oral" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="adenovirus, type 7"/>
                </concept>
                <concept code="56" codeSystem="2.16.840.1.113883.12.292" displayName="dengue fever vaccine, tetravalent" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="dengue fever tetravalent"/>
                </concept>
                <concept code="57" codeSystem="2.16.840.1.113883.12.292" displayName="hantavirus vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="hantavirus"/>
                </concept>
                <concept code="58" codeSystem="2.16.840.1.113883.12.292" displayName="hepatitis C vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hep C"/>
                </concept>
                <concept code="59" codeSystem="2.16.840.1.113883.12.292" displayName="hepatitis E vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hep E"/>
                </concept>
                <concept code="60" codeSystem="2.16.840.1.113883.12.292" displayName="herpes simplex virus, type 2 vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="herpes simplex 2"/>
                </concept>
                <concept code="61" codeSystem="2.16.840.1.113883.12.292" displayName="human immunodeficiency virus vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="HIV"/>
                </concept>
                <concept code="62" codeSystem="2.16.840.1.113883.12.292" displayName="human papilloma virus vaccine, quadrivalent" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="HPV, quadrivalent"/>
                </concept>
                <concept code="63" codeSystem="2.16.840.1.113883.12.292" displayName="Junin virus vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Junin virus"/>
                </concept>
                <concept code="64" codeSystem="2.16.840.1.113883.12.292" displayName="leishmaniasis vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="leishmaniasis"/>
                </concept>
                <concept code="65" codeSystem="2.16.840.1.113883.12.292" displayName="leprosy vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="leprosy"/>
                </concept>
                <concept code="66" codeSystem="2.16.840.1.113883.12.292" displayName="Lyme disease vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Lyme disease"/>
                </concept>
                <concept code="67" codeSystem="2.16.840.1.113883.12.292" displayName="malaria vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="malaria"/>
                </concept>
                <concept code="68" codeSystem="2.16.840.1.113883.12.292" displayName="melanoma vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="melanoma"/>
                </concept>
                <concept code="69" codeSystem="2.16.840.1.113883.12.292" displayName="parainfluenza-3 virus vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="parainfluenza-3"/>
                </concept>
                <concept code="70" codeSystem="2.16.840.1.113883.12.292" displayName="Q fever vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Q fever"/>
                </concept>
                <concept code="71" codeSystem="2.16.840.1.113883.12.292" displayName="respiratory syncytial virus immune globulin, intravenous" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="RSV-IGIV"/>
                </concept>
                <concept code="72" codeSystem="2.16.840.1.113883.12.292" displayName="rheumatic fever vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="rheumatic fever"/>
                </concept>
                <concept code="73" codeSystem="2.16.840.1.113883.12.292" displayName="Rift Valley fever vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Rift Valley fever"/>
                </concept>
                <concept code="74" codeSystem="2.16.840.1.113883.12.292" displayName="rotavirus, live, tetravalent vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="rotavirus, tetravalent"/>
                </concept>
                <concept code="75" codeSystem="2.16.840.1.113883.12.292" displayName="vaccinia (smallpox) vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="vaccinia (smallpox)"/>
                </concept>
                <concept code="76" codeSystem="2.16.840.1.113883.12.292" displayName="Staphylococcus bacteriophage lysate" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Staphylococcus bacterio lysate"/>
                </concept>
                <concept code="77" codeSystem="2.16.840.1.113883.12.292" displayName="Tick-borne encephalitis vaccine (non-US)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Tick-borne encephalitis vaccine (non-US)"/>
                </concept>
                <concept code="78" codeSystem="2.16.840.1.113883.12.292" displayName="tularemia vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="tularemia vaccine"/>
                </concept>
                <concept code="79" codeSystem="2.16.840.1.113883.12.292" displayName="vaccinia immune globulin" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="vaccinia immune globulin"/>
                </concept>
                <concept code="80" codeSystem="2.16.840.1.113883.12.292" displayName="Venezuelan equine encephalitis, live, attenuated" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="VEE, live"/>
                </concept>
                <concept code="81" codeSystem="2.16.840.1.113883.12.292" displayName="Venezuelan equine encephalitis, inactivated" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="VEE, inactivated"/>
                </concept>
                <concept code="82" codeSystem="2.16.840.1.113883.12.292" displayName="adenovirus vaccine, unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="adenovirus, unspecified formulation"/>
                </concept>
                <concept code="83" codeSystem="2.16.840.1.113883.12.292" displayName="hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hep A, ped/adol, 2 dose"/>
                </concept>
                <concept code="84" codeSystem="2.16.840.1.113883.12.292" displayName="hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hep A, ped/adol, 3 dose"/>
                </concept>
                <concept code="85" codeSystem="2.16.840.1.113883.12.292" displayName="hepatitis A vaccine, unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hep A, unspecified formulation"/>
                </concept>
                <concept code="86" codeSystem="2.16.840.1.113883.12.292" displayName="immune globulin, intramuscular" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="IG"/>
                </concept>
                <concept code="87" codeSystem="2.16.840.1.113883.12.292" displayName="immune globulin, intravenous" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="IGIV"/>
                </concept>
                <concept code="88" codeSystem="2.16.840.1.113883.12.292" displayName="influenza virus vaccine, unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="influenza, unspecified formulation"/>
                </concept>
                <concept code="89" codeSystem="2.16.840.1.113883.12.292" displayName="poliovirus vaccine, unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="polio, unspecified formulation"/>
                </concept>
                <concept code="90" codeSystem="2.16.840.1.113883.12.292" displayName="rabies vaccine, unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="rabies, unspecified formulation"/>
                </concept>
                <concept code="91" codeSystem="2.16.840.1.113883.12.292" displayName="typhoid vaccine, unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="typhoid, unspecified formulation"/>
                </concept>
                <concept code="92" codeSystem="2.16.840.1.113883.12.292" displayName="Venezuelan equine encephalitis vaccine, unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="VEE, unspecified formulation"/>
                </concept>
                <concept code="93" codeSystem="2.16.840.1.113883.12.292" displayName="respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="RSV-MAb"/>
                </concept>
                <concept code="94" codeSystem="2.16.840.1.113883.12.292" displayName="measles, mumps, rubella, and varicella virus vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="MMRV"/>
                </concept>
                <concept code="95" codeSystem="2.16.840.1.113883.12.292" displayName="tuberculin skin test; old tuberculin, multipuncture device" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="TST-OT tine test"/>
                </concept>
                <concept code="96" codeSystem="2.16.840.1.113883.12.292" displayName="tuberculin skin test; purified protein derivative solution, intradermal" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="TST-PPD intradermal"/>
                </concept>
                <concept code="97" codeSystem="2.16.840.1.113883.12.292" displayName="tuberculin skin test; purified protein derivative, multipuncture device" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="TST-PPD tine test"/>
                </concept>
                <concept code="98" codeSystem="2.16.840.1.113883.12.292" displayName="tuberculin skin test; unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="TST, unspecified formulation"/>
                </concept>
                <concept code="99" codeSystem="2.16.840.1.113883.12.292" displayName="RESERVED - do not use" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="RESERVED - do not use"/>
                </concept>
                <concept code="100" codeSystem="2.16.840.1.113883.12.292" displayName="pneumococcal conjugate vaccine, 7 valent" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="pneumococcal conjugate PCV 7"/>
                </concept>
                <concept code="101" codeSystem="2.16.840.1.113883.12.292" displayName="typhoid Vi capsular polysaccharide vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="typhoid, ViCPs"/>
                </concept>
                <concept code="102" codeSystem="2.16.840.1.113883.12.292" displayName="DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="DTP-Hib-Hep B"/>
                </concept>
                <concept code="103" codeSystem="2.16.840.1.113883.12.292" displayName="meningococcal C conjugate vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="meningococcal C conjugate"/>
                </concept>
                <concept code="104" codeSystem="2.16.840.1.113883.12.292" displayName="hepatitis A and hepatitis B vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hep A-Hep B"/>
                </concept>
                <concept code="105" codeSystem="2.16.840.1.113883.12.292" displayName="vaccinia (smallpox) vaccine, diluted" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="vaccinia (smallpox) diluted"/>
                </concept>
                <concept code="106" codeSystem="2.16.840.1.113883.12.292" displayName="diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="DTaP, 5 pertussis antigens"/>
                </concept>
                <concept code="107" codeSystem="2.16.840.1.113883.12.292" displayName="diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="DTaP, unspecified formulation"/>
                </concept>
                <concept code="108" codeSystem="2.16.840.1.113883.12.292" displayName="meningococcal ACWY vaccine, unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="meningococcal ACWY, unspecified formulation"/>
                </concept>
                <concept code="109" codeSystem="2.16.840.1.113883.12.292" displayName="pneumococcal vaccine, unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="pneumococcal, unspecified formulation"/>
                </concept>
                <concept code="110" codeSystem="2.16.840.1.113883.12.292" displayName="DTaP-hepatitis B and poliovirus vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="DTaP-Hep B-IPV"/>
                </concept>
                <concept code="111" codeSystem="2.16.840.1.113883.12.292" displayName="influenza virus vaccine, live, attenuated, for intranasal use" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="influenza, live, intranasal"/>
                </concept>
                <concept code="112" codeSystem="2.16.840.1.113883.12.292" displayName="tetanus toxoid, unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="tetanus toxoid, unspecified formulation"/>
                </concept>
                <concept code="113" codeSystem="2.16.840.1.113883.12.292" displayName="tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed"/>
                </concept>
                <concept code="114" codeSystem="2.16.840.1.113883.12.292" displayName="meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="meningococcal MCV4P"/>
                </concept>
                <concept code="115" codeSystem="2.16.840.1.113883.12.292" displayName="tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Tdap"/>
                </concept>
                <concept code="116" codeSystem="2.16.840.1.113883.12.292" displayName="rotavirus, live, pentavalent vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="rotavirus, pentavalent"/>
                </concept>
                <concept code="117" codeSystem="2.16.840.1.113883.12.292" displayName="varicella zoster immune globulin (Investigational New Drug)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="VZIG (IND)"/>
                </concept>
                <concept code="118" codeSystem="2.16.840.1.113883.12.292" displayName="human papilloma virus vaccine, bivalent" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="HPV, bivalent"/>
                </concept>
                <concept code="119" codeSystem="2.16.840.1.113883.12.292" displayName="rotavirus, live, monovalent vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="rotavirus, monovalent"/>
                </concept>
                <concept code="120" codeSystem="2.16.840.1.113883.12.292" displayName="diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="DTaP-Hib-IPV"/>
                </concept>
                <concept code="121" codeSystem="2.16.840.1.113883.12.292" displayName="zoster vaccine, live" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="zoster live"/>
                </concept>
                <concept code="122" codeSystem="2.16.840.1.113883.12.292" displayName="rotavirus vaccine, unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="rotavirus, unspecified formulation"/>
                </concept>
                <concept code="123" codeSystem="2.16.840.1.113883.12.292" displayName="influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="influenza, H5N1-1203"/>
                </concept>
                <concept code="125" codeSystem="2.16.840.1.113883.12.292" displayName="Novel Influenza-H1N1-09, live virus for nasal administration" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Novel Influenza-H1N1-09, nasal"/>
                </concept>
                <concept code="126" codeSystem="2.16.840.1.113883.12.292" displayName="Novel influenza-H1N1-09, preservative-free, injectable" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Novel influenza-H1N1-09, preservative-free"/>
                </concept>
                <concept code="127" codeSystem="2.16.840.1.113883.12.292" displayName="Novel influenza-H1N1-09, injectable" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Novel influenza-H1N1-09"/>
                </concept>
                <concept code="128" codeSystem="2.16.840.1.113883.12.292" displayName="Novel influenza-H1N1-09, all formulations" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Novel Influenza-H1N1-09, all formulations"/>
                </concept>
                <concept code="129" codeSystem="2.16.840.1.113883.12.292" displayName="Japanese Encephalitis vaccine, unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Japanese Encephalitis, unspecified formulation"/>
                </concept>
                <concept code="130" codeSystem="2.16.840.1.113883.12.292" displayName="Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="DTaP-IPV"/>
                </concept>
                <concept code="131" codeSystem="2.16.840.1.113883.12.292" displayName="Historical record of a typhus vaccination" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="typhus, historical"/>
                </concept>
                <concept code="132" codeSystem="2.16.840.1.113883.12.292" displayName="Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine." level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="DTaP-IPV-HIB-HEP B, historical"/>
                </concept>
                <concept code="133" codeSystem="2.16.840.1.113883.12.292" displayName="pneumococcal conjugate vaccine, 13 valent" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Pneumococcal conjugate PCV 13"/>
                </concept>
                <concept code="134" codeSystem="2.16.840.1.113883.12.292" displayName="Japanese Encephalitis vaccine for intramuscular administration" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Japanese Encephalitis IM"/>
                </concept>
                <concept code="135" codeSystem="2.16.840.1.113883.12.292" displayName="influenza, high dose seasonal, preservative-free" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Influenza, high dose seasonal"/>
                </concept>
                <concept code="136" codeSystem="2.16.840.1.113883.12.292" displayName="meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Meningococcal MCV4O"/>
                </concept>
                <concept code="137" codeSystem="2.16.840.1.113883.12.292" displayName="HPV, unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="HPV, unspecified formulation"/>
                </concept>
                <concept code="138" codeSystem="2.16.840.1.113883.12.292" displayName="tetanus and diphtheria toxoids, not adsorbed, for adult use" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Td (adult)"/>
                </concept>
                <concept code="139" codeSystem="2.16.840.1.113883.12.292" displayName="Td(adult) unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Td(adult) unspecified formulation"/>
                </concept>
                <concept code="140" codeSystem="2.16.840.1.113883.12.292" displayName="Influenza, seasonal, injectable, preservative free" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Influenza, seasonal, injectable, preservative free"/>
                </concept>
                <concept code="141" codeSystem="2.16.840.1.113883.12.292" displayName="Influenza, seasonal, injectable" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Influenza, seasonal, injectable"/>
                </concept>
                <concept code="142" codeSystem="2.16.840.1.113883.12.292" displayName="tetanus toxoid, not adsorbed" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="tetanus toxoid, not adsorbed"/>
                </concept>
                <concept code="143" codeSystem="2.16.840.1.113883.12.292" displayName="Adenovirus, type 4 and type 7, live, oral" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Adenovirus types 4 and 7"/>
                </concept>
                <concept code="144" codeSystem="2.16.840.1.113883.12.292" displayName="seasonal influenza, intradermal, preservative free" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="influenza, seasonal, intradermal, preservative free"/>
                </concept>
                <concept code="145" codeSystem="2.16.840.1.113883.12.292" displayName="respiratory syncytial virus monoclonal antibody (motavizumab), intramuscular" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="RSV-MAb (new)"/>
                </concept>
                <concept code="146" codeSystem="2.16.840.1.113883.12.292" displayName="Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine." level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="DTaP,IPV,Hib,HepB"/>
                </concept>
                <concept code="147" codeSystem="2.16.840.1.113883.12.292" displayName="Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="meningococcal MCV4, unspecified formulation"/>
                </concept>
                <concept code="148" codeSystem="2.16.840.1.113883.12.292" displayName="Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Meningococcal C/Y-HIB PRP"/>
                </concept>
                <concept code="149" codeSystem="2.16.840.1.113883.12.292" displayName="influenza, live, intranasal, quadrivalent" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="influenza, live, intranasal, quadrivalent"/>
                </concept>
                <concept code="150" codeSystem="2.16.840.1.113883.12.292" displayName="Influenza, injectable, quadrivalent, preservative free" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="influenza, injectable, quadrivalent, preservative free"/>
                </concept>
                <concept code="151" codeSystem="2.16.840.1.113883.12.292" displayName="influenza nasal, unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="influenza nasal, unspecified formulation"/>
                </concept>
                <concept code="152" codeSystem="2.16.840.1.113883.12.292" displayName="Pneumococcal Conjugate, unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Pneumococcal Conjugate, unspecified formulation"/>
                </concept>
                <concept code="153" codeSystem="2.16.840.1.113883.12.292" displayName="Influenza, injectable, Madin Darby Canine Kidney, preservative free" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Influenza, injectable, MDCK, preservative free"/>
                </concept>
                <concept code="154" codeSystem="2.16.840.1.113883.12.292" displayName="Hepatitis A immune globulin" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hep A, IG"/>
                </concept>
                <concept code="155" codeSystem="2.16.840.1.113883.12.292" displayName="Seasonal, trivalent, recombinant, injectable influenza vaccine, preservative free" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="influenza, recombinant, injectable, preservative free"/>
                </concept>
                <concept code="156" codeSystem="2.16.840.1.113883.12.292" displayName="Rho(D) Immune globulin- IV or IM" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Rho(D)-IG"/>
                </concept>
                <concept code="157" codeSystem="2.16.840.1.113883.12.292" displayName="Rho(D) Immune globulin - IM" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Rho(D) -IG IM"/>
                </concept>
                <concept code="158" codeSystem="2.16.840.1.113883.12.292" displayName="influenza, injectable, quadrivalent, contains preservative" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="influenza, injectable, quadrivalent"/>
                </concept>
                <concept code="159" codeSystem="2.16.840.1.113883.12.292" displayName="Rho(D) Unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Rho(D) - Unspecified formulation"/>
                </concept>
                <concept code="160" codeSystem="2.16.840.1.113883.12.292" displayName="Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Influenza A monovalent (H5N1), ADJUVANTED-2013"/>
                </concept>
                <concept code="161" codeSystem="2.16.840.1.113883.12.292" displayName="Influenza, injectable,quadrivalent, preservative free, pediatric" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Influenza, injectable,quadrivalent, preservative free, pediatric"/>
                </concept>
                <concept code="162" codeSystem="2.16.840.1.113883.12.292" displayName="meningococcal B vaccine, fully recombinant" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="meningococcal B, recombinant"/>
                </concept>
                <concept code="163" codeSystem="2.16.840.1.113883.12.292" displayName="meningococcal B vaccine, recombinant, OMV, adjuvanted" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="meningococcal B, OMV"/>
                </concept>
                <concept code="164" codeSystem="2.16.840.1.113883.12.292" displayName="meningococcal B, unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="meningococcal B, unspecified"/>
                </concept>
                <concept code="165" codeSystem="2.16.840.1.113883.12.292" displayName="Human Papillomavirus 9-valent vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="HPV9"/>
                </concept>
                <concept code="166" codeSystem="2.16.840.1.113883.12.292" displayName="influenza, intradermal, quadrivalent, preservative free, injectable" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="influenza, intradermal, quadrivalent, preservative free"/>
                </concept>
                <concept code="167" codeSystem="2.16.840.1.113883.12.292" displayName="meningococcal vaccine of unknown formulation and unknown serogroups" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="meningococcal, unknown serogroups"/>
                </concept>
                <concept code="168" codeSystem="2.16.840.1.113883.12.292" displayName="Seasonal trivalent influenza vaccine, adjuvanted, preservative free" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="influenza, trivalent, adjuvanted"/>
                </concept>
                <concept code="169" codeSystem="2.16.840.1.113883.12.292" displayName="Hep A, live attenuated-IM" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hep A, live attenuated"/>
                </concept>
                <concept code="170" codeSystem="2.16.840.1.113883.12.292" displayName="non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="DTAP/IPV/HIB - non-US"/>
                </concept>
                <concept code="171" codeSystem="2.16.840.1.113883.12.292" displayName="Influenza, injectable, Madin Darby Canine Kidney, preservative free, quadrivalent" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Influenza, injectable, MDCK, preservative free, quadrivalent"/>
                </concept>
                <concept code="172" codeSystem="2.16.840.1.113883.12.292" displayName="cholera, WC-rBS" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="cholera, WC-rBS"/>
                </concept>
                <concept code="173" codeSystem="2.16.840.1.113883.12.292" displayName="cholera, BivWC" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="cholera, BivWC"/>
                </concept>
                <concept code="174" codeSystem="2.16.840.1.113883.12.292" displayName="cholera, live attenuated" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="cholera, live attenuated"/>
                </concept>
                <concept code="175" codeSystem="2.16.840.1.113883.12.292" displayName="Human Rabies vaccine from human diploid cell culture" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Rabies - IM Diploid cell culture"/>
                </concept>
                <concept code="176" codeSystem="2.16.840.1.113883.12.292" displayName="Human rabies vaccine from Chicken fibroblast culture" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Rabies - IM fibroblast culture"/>
                </concept>
                <concept code="177" codeSystem="2.16.840.1.113883.12.292" displayName="pneumococcal conjugate vaccine, 10 valent" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="PCV10"/>
                </concept>
                <concept code="178" codeSystem="2.16.840.1.113883.12.292" displayName="Non-US bivalent oral polio vaccine (types 1 and 3)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="OPV bivalent"/>
                </concept>
                <concept code="179" codeSystem="2.16.840.1.113883.12.292" displayName="Non-US monovalent oral polio vaccine, unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="OPV ,monovalent, unspecified"/>
                </concept>
                <concept code="180" codeSystem="2.16.840.1.113883.12.292" displayName="tetanus immune globulin" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="tetanus immune globulin"/>
                </concept>
                <concept code="181" codeSystem="2.16.840.1.113883.12.292" displayName="anthrax immune globulin" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="anthrax immune globulin"/>
                </concept>
                <concept code="182" codeSystem="2.16.840.1.113883.12.292" displayName="Oral Polio Vaccine, Unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="OPV, Unspecified"/>
                </concept>
                <concept code="183" codeSystem="2.16.840.1.113883.12.292" displayName="Yellow fever vaccine alternative formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Yellow fever vaccine - alt"/>
                </concept>
                <concept code="184" codeSystem="2.16.840.1.113883.12.292" displayName="Yellow fever vaccine, unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Yellow fever, unspecified formulation"/>
                </concept>
                <concept code="185" codeSystem="2.16.840.1.113883.12.292" displayName="Seasonal, quadrivalent, recombinant, injectable influenza vaccine, preservative free" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="influenza, recombinant, quadrivalent,injectable, preservative free"/>
                </concept>
                <concept code="186" codeSystem="2.16.840.1.113883.12.292" displayName="Influenza, injectable, Madin Darby Canine Kidney, quadrivalent with preservative" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Influenza, injectable, MDCK, quadrivalent, preservative"/>
                </concept>
                <concept code="187" codeSystem="2.16.840.1.113883.12.292" displayName="zoster vaccine recombinant" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="zoster recombinant"/>
                </concept>
                <concept code="188" codeSystem="2.16.840.1.113883.12.292" displayName="zoster vaccine, unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="zoster, unspecified formulation"/>
                </concept>
                <concept code="189" codeSystem="2.16.840.1.113883.12.292" displayName="Hepatitis B vaccine (recombinant), CpG adjuvanted" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="HepB-CpG"/>
                </concept>
                <concept code="190" codeSystem="2.16.840.1.113883.12.292" displayName="Typhoid conjugate vaccine (non-US)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Typhoid conjugate vaccine (TCV)"/>
                </concept>
                <concept code="191" codeSystem="2.16.840.1.113883.12.292" displayName="meningococcal A polysaccharide vaccine (non-US)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="meningococcal A polysaccharide (non-US)"/>
                </concept>
                <concept code="192" codeSystem="2.16.840.1.113883.12.292" displayName="meningococcal AC polysaccharide vaccine (non-US)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="meningococcal AC polysaccharide (non-US)"/>
                </concept>
                <concept code="193" codeSystem="2.16.840.1.113883.12.292" displayName="hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hep A-Hep B, pediatric/adolescent"/>
                </concept>
                <concept code="194" codeSystem="2.16.840.1.113883.12.292" displayName="influenza, Southern Hemisphere, unspecified formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Influenza, Southern Hemisphere"/>
                </concept>
                <concept code="195" codeSystem="2.16.840.1.113883.12.292" displayName="Diphtheria, Tetanus, Poliomyelitis adsorbed" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="DT, IPV adsorbed"/>
                </concept>
                <concept code="196" codeSystem="2.16.840.1.113883.12.292" displayName="tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Td, adsorbed, preservative free, adult use, Lf unspecified"/>
                </concept>
                <concept code="197" codeSystem="2.16.840.1.113883.12.292" displayName="influenza, high-dose seasonal, quadrivalent, 0.7mL dose, preservative free" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="influenza, high-dose, quadrivalent"/>
                </concept>
                <concept code="198" codeSystem="2.16.840.1.113883.12.292" displayName="Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="DTP-hepB-Hib Pentavalent Non-US"/>
                </concept>
                <concept code="200" codeSystem="2.16.840.1.113883.12.292" displayName="influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="influenza, Southern Hemisphere, pediatric, preservative free"/>
                </concept>
                <concept code="201" codeSystem="2.16.840.1.113883.12.292" displayName="influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="influenza, Southern Hemisphere, preservative free"/>
                </concept>
                <concept code="202" codeSystem="2.16.840.1.113883.12.292" displayName="influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="influenza, Southern Hemisphere, quadrivalent, with preservative"/>
                </concept>
                <concept code="203" codeSystem="2.16.840.1.113883.12.292" displayName="meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)"/>
                </concept>
                <concept code="204" codeSystem="2.16.840.1.113883.12.292" displayName="Ebola Zaire vaccine, live, recombinant, 1mL dose" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Ebola Zaire vaccine, live, recombinant, 1mL dose"/>
                </concept>
                <concept code="205" codeSystem="2.16.840.1.113883.12.292" displayName="influenza, seasonal vaccine, quadrivalent, adjuvanted, 0.5mL dose, preservative free" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Influenza vaccine, quadrivalent, adjuvanted"/>
                </concept>
                <concept code="206" codeSystem="2.16.840.1.113883.12.292" displayName="Vaccinia, smallpox monkeypox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection"/>
                </concept>
                <concept code="207" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose"/>
                </concept>
                <concept code="208" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose"/>
                </concept>
                <concept code="210" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL"/>
                </concept>
                <concept code="211" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL"/>
                </concept>
                <concept code="212" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL"/>
                </concept>
                <concept code="213" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED"/>
                </concept>
                <concept code="214" codeSystem="2.16.840.1.113883.12.292" displayName="Ebola, unspecified" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Ebola, unspecified"/>
                </concept>
                <concept code="215" codeSystem="2.16.840.1.113883.12.292" displayName="Pneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF"/>
                </concept>
                <concept code="216" codeSystem="2.16.840.1.113883.12.292" displayName="Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF"/>
                </concept>
                <concept code="217" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose"/>
                </concept>
                <concept code="218" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose"/>
                </concept>
                <concept code="219" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose"/>
                </concept>
                <concept code="220" codeSystem="2.16.840.1.113883.12.292" displayName="Hepatitis B vaccine (recombinant), 3-antigen, Al(OH)3 adjuvanted" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="HepB recombinant, 3-antigen, Al(OH)3"/>
                </concept>
                <concept code="221" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose"/>
                </concept>
                <concept code="222" codeSystem="2.16.840.1.113883.12.292" displayName="Tick-borne encephalitis vaccine, unspecified" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Tick-borne encephalitis, unspecified"/>
                </concept>
                <concept code="223" codeSystem="2.16.840.1.113883.12.292" displayName="Tick-borne encephalitis vaccine, inactivated, preservative free, 0.25mL dose" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Tick-borne encephalitis, inactivated, PF, 0.25mL"/>
                </concept>
                <concept code="224" codeSystem="2.16.840.1.113883.12.292" displayName="Tick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Tick-borne encephalitis, inactivated, PF, 0.5mL"/>
                </concept>
                <concept code="225" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 5mcg/0.5mL dose" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL"/>
                </concept>
                <concept code="226" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 10mcg/0.5mL dose" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL"/>
                </concept>
                <concept code="227" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose"/>
                </concept>
                <concept code="228" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose"/>
                </concept>
                <concept code="229" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose"/>
                </concept>
                <concept code="230" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL"/>
                </concept>
                <concept code="231" codeSystem="2.16.840.1.113883.12.292" displayName="influenza, seasonal, Southern Hemisphere, high-dose, quadrivalent, 0.7mL dose, preservative free" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="influenza, Southern Hemisphere, high-dose, quadrivalent"/>
                </concept>
                <concept code="300" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose"/>
                </concept>
                <concept code="301" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose"/>
                </concept>
                <concept code="302" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose"/>
                </concept>
                <concept code="303" codeSystem="2.16.840.1.113883.12.292" displayName="Respiratory syncytial virus (RSV), vaccine, recombinant, protein subunit RSV prefusion F, adjuvant reconstituted, 0.5 mL, preservative free" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF"/>
                </concept>
                <concept code="304" codeSystem="2.16.840.1.113883.12.292" displayName="Respiratory syncytial virus (RSV), unspecified" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Respiratory syncytial virus (RSV), unspecified"/>
                </concept>
                <concept code="305" codeSystem="2.16.840.1.113883.12.292" displayName="Respiratory syncytial virus (RSV), vaccine, bivalent, protein subunit RSV prefusion F, diluent reconstituted, 0.5 mL, preservative free" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF"/>
                </concept>
                <concept code="306" codeSystem="2.16.840.1.113883.12.292" displayName="Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ , (nirsevimab-alip), 0.5 mL, neonates and children to 24 months" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months"/>
                </concept>
                <concept code="307" codeSystem="2.16.840.1.113883.12.292" displayName="Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ , (nirsevimab-alip), 1 mL, neonates and children to 24 months" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months"/>
                </concept>
                <concept code="308" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 3 mcg/0.3 mL dose" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL"/>
                </concept>
                <concept code="309" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL"/>
                </concept>
                <concept code="310" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL"/>
                </concept>
                <concept code="311" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL"/>
                </concept>
                <concept code="312" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL"/>
                </concept>
                <concept code="313" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 5 mcg/0.5 mL dose" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL"/>
                </concept>
                <concept code="314" codeSystem="2.16.840.1.113883.12.292" displayName="Respiratory syncytial virus (RSV) vaccine, unspecified" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Respiratory syncytial virus (RSV) vaccine, unspecified"/>
                </concept>
                <concept code="315" codeSystem="2.16.840.1.113883.12.292" displayName="Respiratory syncytial virus (RSV) monoclonal antibody (MAB), unspecified" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Respiratory syncytial virus (RSV) MAB, unspecified"/>
                </concept>
                <concept code="316" codeSystem="2.16.840.1.113883.12.292" displayName="meningococcal polysaccharide (groups A, C, Y, W) tetanus toxoid conjugate, meningococcal B recombinant vaccine, 0.5mL, preservative free" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF"/>
                </concept>
                <concept code="317" codeSystem="2.16.840.1.113883.12.292" displayName="Chikungunya, live attenuated vaccine, 0.5 mL, preservative free" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Chikungunya live attenuated vaccine, 0.5 mL, PF"/>
                </concept>
                <concept code="500" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 COVID-19 Non-US Vaccine, Specific Product Unknown" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19 Non-US Vaccine, Product Unknown"/>
                </concept>
                <concept code="501" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19 IV Non-US Vaccine (QAZCOVID-IN)"/>
                </concept>
                <concept code="502" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19 IV Non-US Vaccine (COVAXIN)"/>
                </concept>
                <concept code="503" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19 LAV Non-US Vaccine (COVIVAC)"/>
                </concept>
                <concept code="504" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19 VVnr Non-US Vaccine (Sputnik Light)"/>
                </concept>
                <concept code="505" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19 VVnr Non-US Vaccine (Sputnik V)"/>
                </concept>
                <concept code="506" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology"/>
                </concept>
                <concept code="507" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)"/>
                </concept>
                <concept code="508" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)"/>
                </concept>
                <concept code="509" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19 PS Non-US Vaccine (EpiVacCorona)"/>
                </concept>
                <concept code="510" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)"/>
                </concept>
                <concept code="511" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)"/>
                </concept>
                <concept code="512" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)"/>
                </concept>
                <concept code="513" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)"/>
                </concept>
                <concept code="514" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)"/>
                </concept>
                <concept code="515" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)"/>
                </concept>
                <concept code="516" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)"/>
                </concept>
                <concept code="517" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)"/>
                </concept>
                <concept code="518" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)"/>
                </concept>
                <concept code="519" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna"/>
                </concept>
                <concept code="520" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech"/>
                </concept>
                <concept code="521" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK"/>
                </concept>
                <concept code="801" codeSystem="2.16.840.1.113883.12.292" displayName="AS03 Adjuvant" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="AS03 Adjuvant"/>
                </concept>
                <concept code="998" codeSystem="2.16.840.1.113883.12.292" displayName="no vaccine administered" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="no vaccine administered"/>
                </concept>
                <concept code="999" codeSystem="2.16.840.1.113883.12.292" displayName="unknown vaccine or immune globulin" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="unknown"/>
                </concept>
            </conceptList>
        </valueSet>
        <valueSet id="2.16.840.1.113883.3.1937.99.60.14.11.2" name="CVxgroups" displayName="Vaccine Administered (CVX) Groups" effectiveDate="2025-04-26T00:00:00" statusCode="draft" lastModifiedDate="2025-04-26T11:51:23">
            <desc language="en-US" lastTranslated="2025-04-04T13:23:33">
                <p>Vaccine Administered (CVX) Groups</p>
                <p style="color: orange">For testing and demo puposes only</p>
            </desc>
            <conceptList>
                <concept code="107" codeSystem="2.16.840.1.113883.12.292" displayName="DTaP-Hib" level="0" type="L"/>
                <concept code="89" codeSystem="2.16.840.1.113883.12.292" displayName="polio, unspecified formulation" level="0" type="L"/>
                <concept code="3" codeSystem="2.16.840.1.113883.12.292" displayName="MMRV" level="0" type="L"/>
                <concept code="45" codeSystem="2.16.840.1.113883.12.292" displayName="Hib-Hep B" level="0" type="L"/>
                <concept code="139" codeSystem="2.16.840.1.113883.12.292" displayName="tetanus toxoid, adsorbed" level="0" type="L"/>
                <concept code="152" codeSystem="2.16.840.1.113883.12.292" displayName="Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF" level="0" type="L"/>
                <concept code="91" codeSystem="2.16.840.1.113883.12.292" displayName="typhoid, unspecified formulation" level="0" type="L"/>
                <concept code="17" codeSystem="2.16.840.1.113883.12.292" displayName="Hib-Hep B" level="0" type="L"/>
                <concept code="108" codeSystem="2.16.840.1.113883.12.292" displayName="Meningococcal oligosaccharide (MenACWY), (MenB), PF" level="0" type="L"/>
                <concept code="85" codeSystem="2.16.840.1.113883.12.292" displayName="Hep A, unspecified formulation" level="0" type="L"/>
                <concept code="75" codeSystem="2.16.840.1.113883.12.292" displayName="vaccinia (smallpox)" level="0" type="L"/>
                <concept code="33" codeSystem="2.16.840.1.113883.12.292" displayName="pneumococcal polysaccharide PPV23" level="0" type="L"/>
                <concept code="88" codeSystem="2.16.840.1.113883.12.292" displayName="influenza, unspecified formulation" level="0" type="L"/>
                <concept code="115" codeSystem="2.16.840.1.113883.12.292" displayName="Tdap" level="0" type="L"/>
                <concept code="122" codeSystem="2.16.840.1.113883.12.292" displayName="rotavirus, tetravalent" level="0" type="L"/>
                <concept code="137" codeSystem="2.16.840.1.113883.12.292" displayName="HPV, quadrivalent" level="0" type="L"/>
                <concept code="188" codeSystem="2.16.840.1.113883.12.292" displayName="zoster, unspecified formulation" level="0" type="L"/>
                <concept code="123" codeSystem="2.16.840.1.113883.12.292" displayName="Influenza A monovalent (H5N1), ADJUVANTED-2013" level="0" type="L"/>
                <concept code="128" codeSystem="2.16.840.1.113883.12.292" displayName="Novel Influenza-H1N1-09, all formulations" level="0" type="L"/>
                <concept code="129" codeSystem="2.16.840.1.113883.12.292" displayName="Japanese encephalitis SC" level="0" type="L"/>
                <concept code="82" codeSystem="2.16.840.1.113883.12.292" displayName="adenovirus, unspecified formulation" level="0" type="L"/>
                <concept code="164" codeSystem="2.16.840.1.113883.12.292" displayName="Meningococcal oligosaccharide (MenACWY), (MenB), PF" level="0" type="L"/>
                <concept code="26" codeSystem="2.16.840.1.113883.12.292" displayName="cholera, unspecified formulation" level="0" type="L"/>
                <concept code="90" codeSystem="2.16.840.1.113883.12.292" displayName="rabies, unspecified formulation" level="0" type="L"/>
                <concept code="184" codeSystem="2.16.840.1.113883.12.292" displayName="yellow fever live" level="0" type="L"/>
                <concept code="19" codeSystem="2.16.840.1.113883.12.292" displayName="BCG" level="0" type="L"/>
                <concept code="214" codeSystem="2.16.840.1.113883.12.292" displayName="Ebola, unspecified" level="0" type="L"/>
                <concept code="213" codeSystem="2.16.840.1.113883.12.292" displayName="COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK" level="0" type="L"/>
                <concept code="21" codeSystem="2.16.840.1.113883.12.292" displayName="MMRV" level="0" type="L"/>
                <concept code="222" codeSystem="2.16.840.1.113883.12.292" displayName="Tick-borne encephalitis vaccine (non-US)" level="0" type="L"/>
                <concept code="23" codeSystem="2.16.840.1.113883.12.292" displayName="plague" level="0" type="L"/>
                <concept code="319" codeSystem="2.16.840.1.113883.12.292" displayName="Anthrax vaccine, unspecified" level="0" type="L"/>
                <concept code="304" codeSystem="2.16.840.1.113883.12.292" displayName="RSV, mRNA, injectable, PF" level="0" type="L"/>
                <concept code="317" codeSystem="2.16.840.1.113883.12.292" displayName="Chikungunya, VLP, recombinant, 0.8 mL, PF" level="0" type="L"/>
                <concept code="323" codeSystem="2.16.840.1.113883.12.292" displayName="Influenza-avian, H5, unspecified formulation" level="0" type="L"/>
                <concept code="56" codeSystem="2.16.840.1.113883.12.292" displayName="dengue fever tetravalent" level="0" type="L"/>
                <concept code="66" codeSystem="2.16.840.1.113883.12.292" displayName="Lyme disease" level="0" type="L"/>
                <concept code="92" codeSystem="2.16.840.1.113883.12.292" displayName="VEE, unspecified formulation" level="0" type="L"/>
            </conceptList>
        </valueSet>
        <valueSet id="2.16.840.1.113883.3.1937.99.60.14.11.3" name="VaccineProductSNOMED-CT" displayName="Vaccine Product (SNOMED-CT)" effectiveDate="2025-04-26T11:29:30" statusCode="draft" lastModifiedDate="2025-04-26T11:29:30">
            <desc language="en-US" lastTranslated="2025-04-04T13:23:33">
                <p>Vaccine Product (SNOMED-CT)</p>
                <p style="color: orange">For testing and demo puposes only</p>
            </desc>
            <conceptList>
                <include op="descendent-of" code="787859002" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product (medicinal product)"/>
            </conceptList>
        </valueSet>
        <valueSet id="2.16.840.1.113883.3.1937.99.60.14.11.4" name="VaccineProductSNOMED-CT" displayName="Vaccine Product Expansion Set (SNOMED-CT)" effectiveDate="2025-04-26T11:29:30" statusCode="draft" lastModifiedDate="2025-06-01T09:38:54">
            <desc language="en-US" lastTranslated="2025-04-04T13:23:33">
                <p>The expanded value set of Vaccine Product (SNOMED-CT) defined in this project, expanded May 2025. </p>
                <p style="color: orange">For testing and demo puposes only</p>
            </desc>
            <conceptList>
                <concept code="37146000" codeSystem="2.16.840.1.113883.6.96" displayName="Typhus vaccine (medicinal product)" level="0" type="L"/>
                <concept code="409568008" codeSystem="2.16.840.1.113883.6.96" displayName="Pentavalent botulinum toxoid vaccine (medicinal product)" level="0" type="L"/>
                <concept code="428601009" codeSystem="2.16.840.1.113883.6.96" displayName="Paratyphoid vaccine (medicinal product)" level="0" type="L"/>
                <concept code="774618008" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only whole cell Bordetella pertussis and Clostridium tetani toxoid adsorbed and Corynebacterium diphtheriae toxoid antigens (medicinal product)" level="0" type="L"/>
                <concept code="775641005" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Clostridium tetani toxoid adsorbed and Corynebacterium diphtheriae toxoid antigens (medicinal product)" level="0" type="L"/>
                <concept code="777725002" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Clostridium tetani toxoid antigen adsorbed (medicinal product)" level="0" type="L"/>
                <concept code="836368004" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing bacteria antigen (medicinal product)" level="0" type="L"/>
                <concept code="836369007" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="836374004" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Hepatitis B virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="836375003" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Hepatitis A virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="836377006" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Influenza virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="836378001" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Japanese encephalitis virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="836379009" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Human papillomavirus antigen (medicinal product)" level="0" type="L"/>
                <concept code="836380007" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Haemophilus influenzae type b antigen (medicinal product)" level="0" type="L"/>
                <concept code="836381006" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Corynebacterium diphtheriae antigen (medicinal product)" level="0" type="L"/>
                <concept code="836382004" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Measles morbillivirus antigen (medicinal product)" level="0" type="L"/>
                <concept code="836383009" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Vibrio cholerae antigen (medicinal product)" level="0" type="L"/>
                <concept code="836384003" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Bacillus anthracis antigen (medicinal product)" level="0" type="L"/>
                <concept code="836385002" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Yellow fever virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="836387005" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Rotavirus antigen (medicinal product)" level="0" type="L"/>
                <concept code="836388000" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Rubella virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="836389008" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Vaccinia virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="836390004" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Salmonella enterica subspecies enterica serovar Typhi antigen (medicinal product)" level="0" type="L"/>
                <concept code="836393002" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Rabies lyssavirus antigen (medicinal product)" level="0" type="L"/>
                <concept code="836397001" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Coxiella burnetii antigen (medicinal product)" level="0" type="L"/>
                <concept code="836398006" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Streptococcus pneumoniae antigen (medicinal product)" level="0" type="L"/>
                <concept code="836400005" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Adenovirus antigen (medicinal product)" level="0" type="L"/>
                <concept code="836401009" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Neisseria meningitidis antigen (medicinal product)" level="0" type="L"/>
                <concept code="836402002" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing live attenuated Mycobacterium bovis antigen (medicinal product)" level="0" type="L"/>
                <concept code="836403007" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Tick-borne encephalitis virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="836421005" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Ebolavirus antigen (medicinal product)" level="0" type="L"/>
                <concept code="836495005" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Human alphaherpesvirus 3 antigen (medicinal product)" level="0" type="L"/>
                <concept code="836498007" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Mumps orthorubulavirus antigen (medicinal product)" level="0" type="L"/>
                <concept code="836500008" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens (medicinal product)" level="0" type="L"/>
                <concept code="840549009" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Yersinia pestis antigen (medicinal product)" level="0" type="L"/>
                <concept code="840551008" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Francisella tularensis antigen (medicinal product)" level="0" type="L"/>
                <concept code="840563003" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Dengue virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="840564009" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Leptospira antigen (medicinal product)" level="0" type="L"/>
                <concept code="840599008" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Borrelia burgdorferi antigen (medicinal product)" level="0" type="L"/>
                <concept code="860722004" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Junin virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="860818003" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Bacillus anthracis antigen (medicinal product)" level="0" type="L"/>
                <concept code="863911006" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Clostridium tetani antigen (medicinal product)" level="0" type="L"/>
                <concept code="863950005" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing bacteria and virus antigens (medicinal product)" level="0" type="L"/>
                <concept code="865997008" codeSystem="2.16.840.1.113883.6.96" displayName="Adult vaccine product containing only Hepatitis A virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="871716003" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Francisella tularensis antigen (medicinal product)" level="0" type="L"/>
                <concept code="871717007" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Yellow fever virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="871718002" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Yersinia pestis antigen (medicinal product)" level="0" type="L"/>
                <concept code="871719005" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Tick-borne encephalitis virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="871720004" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Dengue virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="871721000" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Ebolavirus antigen (medicinal product)" level="0" type="L"/>
                <concept code="871722007" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Adenovirus antigen (medicinal product)" level="0" type="L"/>
                <concept code="871723002" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Coxiella burnetii antigen (medicinal product)" level="0" type="L"/>
                <concept code="871724008" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Japanese encephalitis virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="871725009" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only inactivated whole Japanese encephalitis virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="871726005" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Rabies lyssavirus antigen (medicinal product)" level="0" type="L"/>
                <concept code="871727001" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Vaccinia virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="871729003" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Corynebacterium diphtheriae antigen (medicinal product)" level="0" type="L"/>
                <concept code="871730008" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only low dose Corynebacterium diphtheriae antigen (medicinal product)" level="0" type="L"/>
                <concept code="871732000" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Rubella virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="871737006" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Mumps orthorubulavirus antigen (medicinal product)" level="0" type="L"/>
                <concept code="871738001" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only live attenuated Mumps orthorubulavirus antigen (medicinal product)" level="0" type="L"/>
                <concept code="871739009" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Human poliovirus antigen (medicinal product)" level="0" type="L"/>
                <concept code="871740006" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only inactivated whole Human poliovirus antigen (medicinal product)" level="0" type="L"/>
                <concept code="871742003" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Clostridium tetani antigen (medicinal product)" level="0" type="L"/>
                <concept code="871750007" codeSystem="2.16.840.1.113883.6.96" displayName="Pediatric vaccine product containing only Hepatitis A virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="871751006" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Hepatitis A virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="871755002" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Salmonella enterica subspecies enterica serovar Typhi capsular polysaccharide Vi antigen (medicinal product)" level="0" type="L"/>
                <concept code="871758000" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Bordetella pertussis antigen (medicinal product)" level="0" type="L"/>
                <concept code="871759008" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only acellular Bordetella pertussis antigen (medicinal product)" level="0" type="L"/>
                <concept code="871761004" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Rotavirus antigen (medicinal product)" level="0" type="L"/>
                <concept code="871764007" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Haemophilus influenzae type b antigen (medicinal product)" level="0" type="L"/>
                <concept code="871765008" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Measles morbillivirus antigen (medicinal product)" level="0" type="L"/>
                <concept code="871766009" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only live attenuated Measles morbillivirus antigen (medicinal product)" level="0" type="L"/>
                <concept code="871768005" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Influenza virus antigen in nasal dose form (medicinal product form)" level="0" type="L"/>
                <concept code="871772009" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Influenza A virus subtype H1N1 antigen (medicinal product)" level="0" type="L"/>
                <concept code="871803007" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Hepatitis A and Hepatitis B virus antigens (medicinal product)" level="0" type="L"/>
                <concept code="871804001" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Hepatitis A virus and Salmonella enterica subspecies enterica serovar Typhi antigens (medicinal product)" level="0" type="L"/>
                <concept code="871806004" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Haemophilus influenzae type b and Hepatitis B virus antigens (medicinal product)" level="0" type="L"/>
                <concept code="871816007" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Clostridium tetani and Human poliovirus antigens (medicinal product)" level="0" type="L"/>
                <concept code="871817003" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Measles morbillivirus and Rubella virus antigens (medicinal product)" level="0" type="L"/>
                <concept code="871822003" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Hepatitis B virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="871825001" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only inactivated whole Japanese encephalitis virus antigen adsorbed (medicinal product)" level="0" type="L"/>
                <concept code="871826000" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae antigens (medicinal product)" level="0" type="L"/>
                <concept code="871827009" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Clostridium tetani and low dose Corynebacterium diphtheriae antigens (medicinal product)" level="0" type="L"/>
                <concept code="871830002" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Corynebacterium diphtheriae toxoid antigen (medicinal product)" level="0" type="L"/>
                <concept code="871831003" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (medicinal product)" level="0" type="L"/>
                <concept code="871837004" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens (medicinal product)" level="0" type="L"/>
                <concept code="871838009" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Clostridium tetani and low dose Corynebacterium diphtheriae and inactivated Human poliovirus antigens (medicinal product)" level="0" type="L"/>
                <concept code="871839001" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b antigens (medicinal product)" level="0" type="L"/>
                <concept code="871866001" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Neisseria meningitidis serogroup C antigen (medicinal product)" level="0" type="L"/>
                <concept code="871871008" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Neisseria meningitidis serogroup A and C antigens (medicinal product)" level="0" type="L"/>
                <concept code="871873006" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y antigens (medicinal product)" level="0" type="L"/>
                <concept code="871875004" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens (medicinal product)" level="0" type="L"/>
                <concept code="871876003" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens (medicinal product)" level="0" type="L"/>
                <concept code="871878002" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens (medicinal product)" level="0" type="L"/>
                <concept code="871883005" codeSystem="2.16.840.1.113883.6.96" displayName="Pediatric vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens (medicinal product)" level="0" type="L"/>
                <concept code="871886002" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (medicinal product)" level="0" type="L"/>
                <concept code="871887006" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (medicinal product)" level="0" type="L"/>
                <concept code="871888001" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (medicinal product)" level="0" type="L"/>
                <concept code="871889009" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only acellular Bordetella pertussis and Corynebacterium diphtheriae and Hepatitis B virus and inactivated whole Human poliovirus antigens (medicinal product)" level="0" type="L"/>
                <concept code="871890000" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (medicinal product)" level="0" type="L"/>
                <concept code="871891001" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Hepatitis B virus and inactivated whole Human poliovirus antigens (medicinal product)" level="0" type="L"/>
                <concept code="871893003" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and inactivated whole Human poliovirus antigens (medicinal product)" level="0" type="L"/>
                <concept code="871894009" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and low dose Corynebacterium diphtheriae and inactivated whole Human poliovirus antigens (medicinal product)" level="0" type="L"/>
                <concept code="871895005" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus and Human poliovirus antigens (medicinal product)" level="0" type="L"/>
                <concept code="871897002" codeSystem="2.16.840.1.113883.6.96" displayName="Rocky Mountain spotted fever vaccine (medicinal product)" level="0" type="L"/>
                <concept code="871908002" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (medicinal product)" level="0" type="L"/>
                <concept code="871911001" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Borrelia burgdorferi antigen (medicinal product)" level="0" type="L"/>
                <concept code="871916006" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y capsular oligosaccharide conjugated antigens (medicinal product)" level="0" type="L"/>
                <concept code="871918007" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Rickettsia antigen (medicinal product)" level="0" type="L"/>
                <concept code="871919004" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Human alphaherpesvirus 3 antigen (medicinal product)" level="0" type="L"/>
                <concept code="871921009" codeSystem="2.16.840.1.113883.6.96" displayName="Staphylococcus toxoid vaccine (medicinal product)" level="0" type="L"/>
                <concept code="871925000" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Hepatitis B virus surface protein antigen (medicinal product)" level="0" type="L"/>
                <concept code="871928003" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus and Measles morbillivirus antigens (medicinal product)" level="0" type="L"/>
                <concept code="871929006" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Hepatitis B virus antigens (medicinal product)" level="0" type="L"/>
                <concept code="1003499009" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Influenza A virus subtype H5N1 antigen (medicinal product)" level="0" type="L"/>
                <concept code="1010308001" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only inactivated whole Hepatitis A virus HM-175 strain antigen (medicinal product)" level="0" type="L"/>
                <concept code="1010310004" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only live attenuated Human alphaherpesvirus 3 Oka-Merck strain antigen (medicinal product)" level="0" type="L"/>
                <concept code="1010313002" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only live attenuated Influenza virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="1010318006" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only inactivated whole Hepatitis A virus GBM strain antigen (medicinal product)" level="0" type="L"/>
                <concept code="1010322001" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only live attenuated Human alphaherpesvirus 3 Oka strain antigen (medicinal product)" level="0" type="L"/>
                <concept code="1010689004" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein (medicinal product)" level="0" type="L"/>
                <concept code="1052328007" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Streptococcus pneumoniae Danish serotype 4, 6B, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated (medicinal product)" level="0" type="L"/>
                <concept code="1052330009" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated (medicinal product)" level="0" type="L"/>
                <concept code="1119220001" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens (medicinal product)" level="0" type="L"/>
                <concept code="1119279002" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only inactivated whole Influenza A virus subtype H5N1 antigen (medicinal product)" level="0" type="L"/>
                <concept code="1119305005" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (medicinal product)" level="0" type="L"/>
                <concept code="1119349007" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (medicinal product)" level="0" type="L"/>
                <concept code="1119351006" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C and Y antigens (medicinal product)" level="0" type="L"/>
                <concept code="1156183006" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Human alphaherpesvirus 3 recombinant surface glycoprotein E antigen (medicinal product)" level="0" type="L"/>
                <concept code="1156879008" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Hepatitis B virus antigens (medicinal product)" level="0" type="L"/>
                <concept code="1157024006" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only inactivated whole severe acute respiratory syndrome coronavirus 2 antigen (medicinal product)" level="0" type="L"/>
                <concept code="1157356006" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Influenza A virus A/California/7/2009 (H1N1)-like virus strain split virion hemagglutinin antigen (medicinal product)" level="0" type="L"/>
                <concept code="1162629006" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Influenza A virus A/Indonesia/05/2005 (H5N1)-like virus strain split virion hemagglutinin antigen (medicinal product)" level="0" type="L"/>
                <concept code="1162634005" codeSystem="2.16.840.1.113883.6.96" displayName="Pediatric vaccine product containing only acellular Bordetella pertussis, Clostridium tetani and Corynebacterium diphtheriae toxoids, Haemophilus influenzae type b conjugated, Hepatitis B virus and inactivated Human poliovirus antigens (medicinal product)" level="0" type="L"/>
                <concept code="1162637003" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus and inactivated Human poliovirus antigens (medicinal product)" level="0" type="L"/>
                <concept code="1162643001" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (medicinal product)" level="0" type="L"/>
                <concept code="1187593009" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only severe acute respiratory syndrome coronavirus 2 deoxyribonucleic acid plasmid encoding spike protein (medicinal product)" level="0" type="L"/>
                <concept code="1209197008" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens (medicinal product)" level="0" type="L"/>
                <concept code="1252690003" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Neisseria meningitidis serogroup A antigen (medicinal product)" level="0" type="L"/>
                <concept code="1252703004" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Measles morbillivirus and Mumps orthorubulavirus (medicinal product)" level="0" type="L"/>
                <concept code="1252708008" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, and 33F capsular polysaccharide conjugated antigens (medicinal product)" level="0" type="L"/>
                <concept code="1252709000" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, 33F capsular polysaccharide antigens conjugated (medicinal product)" level="0" type="L"/>
                <concept code="1254676002" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing live attenuated virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="1269346004" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only live attenuated Vaccinia virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="1287338003" codeSystem="2.16.840.1.113883.6.96" displayName="Pediatric vaccine product containing only Tick-borne encephalitis virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="1287595003" codeSystem="2.16.840.1.113883.6.96" displayName="Pediatric vaccine product containing only severe acute respiratory syndrome coronavirus 2 encoding B lineage spike protein and BA.4/BA.5 lineage spike protein messenger ribonucleic acid (medicinal product)" level="0" type="L"/>
                <concept code="1287596002" codeSystem="2.16.840.1.113883.6.96" displayName="Adult vaccine product containing only severe acute respiratory syndrome coronavirus 2 encoding B lineage spike protein and BA.4/BA.5 lineage spike protein messenger ribonucleic acid (medicinal product)" level="0" type="L"/>
                <concept code="1287964002" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only severe acute respiratory syndrome coronavirus 2 encoding B lineage spike protein messenger ribonucleic acid (medicinal product)" level="0" type="L"/>
                <concept code="1290123005" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing protozoa antigen (medicinal product)" level="0" type="L"/>
                <concept code="1290624003" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Variola virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="1290625002" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Variola virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="1290764006" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Human-bovine reassortant Rotavirus G1, G2, G3, G4, and P1A[8] antigens (medicinal product)" level="0" type="L"/>
                <concept code="1293025000" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only modified Vaccinia virus Ankara antigen (medicinal product)" level="0" type="L"/>
                <concept code="1296676008" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only adsorbed Hepatitis B virus recombinant surface antigen (medicinal product)" level="0" type="L"/>
                <concept code="1296677004" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only high dose Hepatitis B virus recombinant surface antigen (medicinal product)" level="0" type="L"/>
                <concept code="1296678009" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only S, preS1, preS2 Hepatitis B virus recombinant surface antigens (medicinal product)" level="0" type="L"/>
                <concept code="1296753004" codeSystem="2.16.840.1.113883.6.96" displayName="Pediatric vaccine product containing only inactivated whole Hepatitis A and Hepatitis B surface antigens (medicinal product)" level="0" type="L"/>
                <concept code="1296864005" codeSystem="2.16.840.1.113883.6.96" displayName="Pediatric vaccine product containing only adsorbed Hepatitis B virus recombinant surface antigen (medicinal product)" level="0" type="L"/>
                <concept code="1297215000" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only live attenuated Rubella virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="1297217008" codeSystem="2.16.840.1.113883.6.96" displayName="Pediatric vaccine product containing only acellular Bordetella pertussis and Clostridium tetani toxoid and Corynebacterium diphtheriae toxoid antigens (medicinal product)" level="0" type="L"/>
                <concept code="1304283008" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Hepatitis B virus recombinant surface antigen (medicinal product)" level="0" type="L"/>
                <concept code="1345036005" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only live attenuated Chikungunya virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="1345042009" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Chikungunya virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="1345202008" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Chikungunya virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="91000221102" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only inactivated whole Hepatitis A virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="121000221105" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only inactivated whole Hepatitis A and Hepatitis B surface antigens (medicinal product)" level="0" type="L"/>
                <concept code="601000221108" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Bordetella pertussis antigen (medicinal product)" level="0" type="L"/>
                <concept code="911000221103" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Human papillomavirus antigen (medicinal product)" level="0" type="L"/>
                <concept code="921000221108" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Neisseria meningitidis antigen (medicinal product)" level="0" type="L"/>
                <concept code="951000221102" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Neisseria meningitidis serogroup C capsular polysaccharide conjugated antigen (medicinal product)" level="0" type="L"/>
                <concept code="961000221100" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Salmonella enterica subspecies enterica serovar Typhi antigen (medicinal product)" level="0" type="L"/>
                <concept code="971000221109" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only live attenuated Salmonella enterica subspecies enterica serovar Typhi antigen in oral dose form (medicinal product form)" level="0" type="L"/>
                <concept code="981000221107" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Streptococcus pneumoniae antigen (medicinal product)" level="0" type="L"/>
                <concept code="991000221105" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Vibrio cholerae antigen (medicinal product)" level="0" type="L"/>
                <concept code="1001000221103" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only inactivated whole Vibrio cholerae antigen in oral dose form (medicinal product form)" level="0" type="L"/>
                <concept code="1011000221100" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only live attenuated Vibrio cholerae antigen in oral dose form (medicinal product form)" level="0" type="L"/>
                <concept code="1031000221108" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Human poliovirus antigen (medicinal product)" level="0" type="L"/>
                <concept code="1051000221104" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only live attenuated Human poliovirus serotypes 1 and 3 antigens in oral dose form (medicinal product form)" level="0" type="L"/>
                <concept code="1061000221102" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Neisseria meningitidis capsular polysaccharide antigen (medicinal product)" level="0" type="L"/>
                <concept code="1081000221109" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only live attenuated Rotavirus antigen (medicinal product)" level="0" type="L"/>
                <concept code="1101000221104" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Clostridium tetani toxoid antigen (medicinal product)" level="0" type="L"/>
                <concept code="1111000221101" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only live attenuated Junin virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="1121000221106" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only live attenuated Yellow fever virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="1131000221109" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only inactivated whole Rabies lyssavirus antigen (medicinal product)" level="0" type="L"/>
                <concept code="1181000221105" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Influenza virus antigen (medicinal product)" level="0" type="L"/>
                <concept code="1801000221105" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Streptococcus pneumoniae capsular polysaccharide antigen conjugated (medicinal product)" level="0" type="L"/>
                <concept code="1861000221106" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only live attenuated Mycobacterium bovis antigen (medicinal product)" level="0" type="L"/>
                <concept code="1971000221105" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y capsular polysaccharide conjugated antigens (medicinal product)" level="0" type="L"/>
                <concept code="1981000221108" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Neisseria meningitidis serogroup B antigen (medicinal product)" level="0" type="L"/>
                <concept code="1991000221106" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Human papillomavirus 16 and 18 antigens (medicinal product)" level="0" type="L"/>
                <concept code="2001000221108" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Human papillomavirus 6, 11, 16 and 18 antigens (medicinal product)" level="0" type="L"/>
                <concept code="2021000221101" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Clostridium tetani toxoid antigen (medicinal product)" level="0" type="L"/>
                <concept code="2031000221103" codeSystem="2.16.840.1.113883.6.96" displayName="Adult vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae toxoids (medicinal product)" level="0" type="L"/>
                <concept code="2041000221105" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Haemophilus influenzae type b capsular polysaccharide antigen conjugated (medicinal product)" level="0" type="L"/>
                <concept code="2051000221107" codeSystem="2.16.840.1.113883.6.96" displayName="Adult vaccine product containing only acellular Bordetella pertussis and Clostridium tetani toxoid and Corynebacterium diphtheriae toxoid antigens (medicinal product)" level="0" type="L"/>
                <concept code="2061000221109" codeSystem="2.16.840.1.113883.6.96" displayName="Pediatric vaccine product containing only whole cell Bordetella pertussis and Clostridium tetani toxoid and Corynebacterium diphtheriae toxoid (medicinal product)" level="0" type="L"/>
                <concept code="2071000221100" codeSystem="2.16.840.1.113883.6.96" displayName="Pediatric vaccine product containing only whole cell Bordetella pertussis and Corynebacterium diphtheriae toxoid and Clostridium tetani toxoid and Haemophilus influenzae type b capsular polysaccharide conjugated antigens (medicinal product)" level="0" type="L"/>
                <concept code="2081000221102" codeSystem="2.16.840.1.113883.6.96" displayName="Pediatric vaccine product containing only acellular Bordetella pertussis, Clostridium tetani and Corynebacterium diphtheriae toxoids, Haemophilus influenzae type b capsular polysaccharide conjugated, Hepatitis B virus surface antigens (medicinal product)" level="0" type="L"/>
                <concept code="2091000221104" codeSystem="2.16.840.1.113883.6.96" displayName="Pediatric vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (medicinal product)" level="0" type="L"/>
                <concept code="2101000221107" codeSystem="2.16.840.1.113883.6.96" displayName="Pediatric vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus and Human poliovirus antigens (medicinal product)" level="0" type="L"/>
                <concept code="2171000221104" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Salmonella enterica subspecies enterica serovar Typhi capsular polysaccharide unconjugated antigen in parenteral dose form (medicinal product form)" level="0" type="L"/>
                <concept code="2181000221101" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Vibrio cholerae antigen in oral dose form (medicinal product form)" level="0" type="L"/>
                <concept code="2191000221103" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only inactivated whole Rabies lyssavirus antigen grown in cellular line (medicinal product)" level="0" type="L"/>
                <concept code="2201000221100" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only inactivated whole Rabies lyssavirus antigen grown in brain tissue (medicinal product)" level="0" type="L"/>
                <concept code="2211000221102" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only influenza A virus subtypes H1N1 and H3N2 and influenza B virus Victoria lineage antigens (medicinal product)" level="0" type="L"/>
                <concept code="2221000221107" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen (medicinal product)" level="0" type="L"/>
                <concept code="2231000221105" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only live attenuated Measles morbillivirus and Rubella virus antigens (medicinal product)" level="0" type="L"/>
                <concept code="2241000221103" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (medicinal product)" level="0" type="L"/>
                <concept code="2251000221101" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus and Human alphaherpesvirus 3 antigens (medicinal product)" level="0" type="L"/>
                <concept code="2261000221104" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only influenza A virus subtypes H1N1 and H3N2 and influenza B virus Victoria and Yamagata lineage antigens (medicinal product)" level="0" type="L"/>
                <concept code="28531000087107" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product against severe acute respiratory syndrome coronavirus 2 (medicinal product)" level="0" type="L"/>
                <concept code="29061000087103" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (medicinal product)" level="0" type="L"/>
                <concept code="30141000087107" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (medicinal product)" level="0" type="L"/>
                <concept code="45861000087106" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing Plasmodium falciparum antigen (medicinal product)" level="0" type="L"/>
                <concept code="45891000087103" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only live attenuated Zaire ebolavirus antigen (medicinal product)" level="0" type="L"/>
                <concept code="51311000087100" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Human orthopneumovirus antigen (medicinal product)" level="0" type="L"/>
                <concept code="51451000087105" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens conjugated (medicinal product)" level="0" type="L"/>
                <concept code="51591000087104" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Enterovirus A71 antigen (medicinal product)" level="0" type="L"/>
                <concept code="52821000087108" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Neisseria meningitidis serogroup A capsular polysaccharide conjugated antigen (medicinal product)" level="0" type="L"/>
                <concept code="318341000221109" codeSystem="2.16.840.1.113883.6.96" displayName="Pediatric vaccine product containing only acellular Bordetella pertussis and Corynebacterium diphtheriae toxoid and Clostridium tetani toxoid and Haemophilus influenzae type b capsular polysaccharide conjugated antigens (medicinal product)" level="0" type="L"/>
                <concept code="318351000221106" codeSystem="2.16.840.1.113883.6.96" displayName="Pediatric vaccine product containing only acellular Bordetella pertussis and Clostridium tetani toxoid and Corynebacterium diphtheriae toxoid and inactivated whole Human Poliovirus serotype 1, 2 and 3 antigens (medicinal product)" level="0" type="L"/>
                <concept code="319941000221104" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only live attenuated Mycobacterium bovis antigen in parenteral dose form (medicinal product form)" level="0" type="L"/>
                <concept code="462321000124107" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only low dose acellular Bordetella pertussis and Clostridium tetani and low dose Corynebacterium diphtheriae antigens (medicinal product)" level="0" type="L"/>
                <concept code="480361000146108" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Bordetella pertussis and Corynebacterium diphtheriae and Haemophilus influenzae type b (medicinal product)" level="0" type="L"/>
                <concept code="480421000146108" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only Corynebacterium diphtheriae and Bordetella pertussis and Clostridium tetani and Human poliovirus antigens and Hepatitis B virus (medicinal product)" level="0" type="L"/>
                <concept code="480431000146105" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only live attenuated Human poliovirus antigens in oral dose form (medicinal product form)" level="0" type="L"/>
                <concept code="480451000146104" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only low dose Corynebacterium diphtheriae, low dose Bordetella pertussis, Clostridium tetani and inactivated Human poliovirus antigens (medicinal product)" level="0" type="L"/>
            </conceptList>
        </valueSet>
        <valueSet id="2.16.840.1.113883.3.1937.99.60.14.11.5" name="eHDSIVaccinesSnomed" displayName="eHDSIVaccines (SNOMED)" effectiveDate="2025-02-17T15:33:02" statusCode="draft">
            <desc language="en-US" lastTranslated="2025-04-04T13:23:33">
                <p>eHDSIVaccines (SNOMED)</p>
                <p style="color: orange">For testing and demo puposes only</p>
            </desc>
            <publishingAuthority name="eHDSI">
                <addrLine>eHealth Digital Service Infrastructure (eHDSI or eHealth DSI) </addrLine>
            </publishingAuthority>
            <conceptList>
                <concept code="1001000221103" codeSystem="2.16.840.1.113883.6.96" displayName="Inactivated whole Vibrio cholerae antigen only vaccine product in oral dose form" level="0" type="L"/>
                <concept code="1011000221100" codeSystem="2.16.840.1.113883.6.96" displayName="Live attenuated Vibrio cholerae antigen only vaccine product in oral dose form" level="0" type="L"/>
                <concept code="1031000221108" codeSystem="2.16.840.1.113883.6.96" displayName="Human poliovirus antigen-containing vaccine product" level="0" type="L"/>
                <concept code="1051000221104" codeSystem="2.16.840.1.113883.6.96" displayName="Live attenuated Human poliovirus serotypes 1 and 3 antigens only vaccine product in oral dose form" level="0" type="L"/>
                <concept code="1052328007" codeSystem="2.16.840.1.113883.6.96" displayName="Streptococcus pneumoniae Danish serotype 4, 6B, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated only vaccine product" level="0" type="L"/>
                <concept code="1081000221109" codeSystem="2.16.840.1.113883.6.96" displayName="Live attenuated Rotavirus antigen only vaccine product" level="0" type="L"/>
                <concept code="1101000221104" codeSystem="2.16.840.1.113883.6.96" displayName="Clostridium tetani toxoid antigen-containing vaccine product" level="0" type="L"/>
                <concept code="1119254000" codeSystem="2.16.840.1.113883.6.96" displayName="Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens only vaccine product" level="0" type="L"/>
                <concept code="1119305005" codeSystem="2.16.840.1.113883.6.96" displayName="SARS-CoV-2 antigen vaccine" level="0" type="L"/>
                <concept code="1119349007" codeSystem="2.16.840.1.113883.6.96" displayName="SARS-CoV-2 mRNA vaccine" level="0" type="L"/>
                <concept code="1121000221106" codeSystem="2.16.840.1.113883.6.96" displayName="Live attenuated Yellow fever virus antigen only vaccine product" level="0" type="L"/>
                <concept code="1131000221109" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccine product containing only inactivated whole Rabies lyssavirus antigen" level="0" type="L"/>
                <concept code="1157024006" codeSystem="2.16.840.1.113883.6.96" displayName="Inactivated whole SARS-CoV-2 antigen vaccine" level="0" type="L"/>
                <concept code="1162643001" codeSystem="2.16.840.1.113883.6.96" displayName="SARS-CoV-2 recombinant spike protein antigen vaccine" level="0" type="L"/>
                <concept code="1181000221105" codeSystem="2.16.840.1.113883.6.96" displayName="Influenza virus antigen only vaccine product" level="0" type="L"/>
                <concept code="1801000221105" codeSystem="2.16.840.1.113883.6.96" displayName="Streptococcus pneumoniae capsular polysaccharide antigen conjugated only vaccine product" level="0" type="L"/>
                <concept code="1861000221106" codeSystem="2.16.840.1.113883.6.96" displayName="Bacillus Calmette-Guerin antigen only vaccine product" level="0" type="L"/>
                <concept code="1981000221108" codeSystem="2.16.840.1.113883.6.96" displayName="Neisseria meningitidis serogroup B antigen only vaccine product" level="0" type="L"/>
                <concept code="2171000221104" codeSystem="2.16.840.1.113883.6.96" displayName="Salmonella enterica subspecies enterica serovar Typhi capsular polysaccharide unconjugated antigen only vaccine product in parenteral dose form" level="0" type="L"/>
                <concept code="2221000221107" codeSystem="2.16.840.1.113883.6.96" displayName="Live attenuated Human alphaherpesvirus 3 only vaccine product" level="0" type="L"/>
                <concept code="28531000087107" codeSystem="2.16.840.1.113883.6.96" displayName="COVID-19 vaccine" level="0" type="L"/>
                <concept code="29061000087103" codeSystem="2.16.840.1.113883.6.96" displayName="COVID-19 non-replicating viral vector vaccine" level="0" type="L"/>
                <concept code="37146000" codeSystem="2.16.840.1.113883.6.96" displayName="Typhus vaccine" level="0" type="L"/>
                <concept code="409568008" codeSystem="2.16.840.1.113883.6.96" displayName="Pentavalent botulinum toxoid vaccine" level="0" type="L"/>
                <concept code="428601009" codeSystem="2.16.840.1.113883.6.96" displayName="Paratyphoid vaccine" level="0" type="L"/>
                <concept code="601000221108" codeSystem="2.16.840.1.113883.6.96" displayName="Bordetella pertussis antigen-containing vaccine product" level="0" type="L"/>
                <concept code="774618008" codeSystem="2.16.840.1.113883.6.96" displayName="Whole cell Bordetella pertussis and Clostridium tetani toxoid adsorbed and Corynebacterium diphtheriae toxoid antigens only vaccine product" level="0" type="L"/>
                <concept code="775641005" codeSystem="2.16.840.1.113883.6.96" displayName="Clostridium tetani toxoid adsorbed and Corynebacterium diphtheriae toxoid antigens only vaccine product" level="0" type="L"/>
                <concept code="777725002" codeSystem="2.16.840.1.113883.6.96" displayName="Clostridium tetani toxoid antigen adsorbed only vaccine product" level="0" type="L"/>
                <concept code="836368004" codeSystem="2.16.840.1.113883.6.96" displayName="Bacteria antigen-containing vaccine product" level="0" type="L"/>
                <concept code="836369007" codeSystem="2.16.840.1.113883.6.96" displayName="Virus antigen-containing vaccine product" level="0" type="L"/>
                <concept code="836374004" codeSystem="2.16.840.1.113883.6.96" displayName="Hepatitis B virus antigen-containing vaccine product" level="0" type="L"/>
                <concept code="836375003" codeSystem="2.16.840.1.113883.6.96" displayName="Hepatitis A virus antigen-containing vaccine product" level="0" type="L"/>
                <concept code="836377006" codeSystem="2.16.840.1.113883.6.96" displayName="Influenza virus antigen-containing vaccine product" level="0" type="L"/>
                <concept code="836378001" codeSystem="2.16.840.1.113883.6.96" displayName="Japanese encephalitis virus antigen-containing vaccine product" level="0" type="L"/>
                <concept code="836379009" codeSystem="2.16.840.1.113883.6.96" displayName="Human papillomavirus antigen-containing vaccine product" level="0" type="L"/>
                <concept code="836380007" codeSystem="2.16.840.1.113883.6.96" displayName="Haemophilus influenzae type B antigen-containing vaccine product" level="0" type="L"/>
                <concept code="836381006" codeSystem="2.16.840.1.113883.6.96" displayName="Corynebacterium diphtheriae antigen-containing vaccine product" level="0" type="L"/>
                <concept code="836382004" codeSystem="2.16.840.1.113883.6.96" displayName="Measles morbillivirus antigen-containing vaccine product" level="0" type="L"/>
                <concept code="836383009" codeSystem="2.16.840.1.113883.6.96" displayName="Vibrio cholerae antigen-containing vaccine product" level="0" type="L"/>
                <concept code="836384003" codeSystem="2.16.840.1.113883.6.96" displayName="Bacillus anthracis antigen-containing vaccine product" level="0" type="L"/>
                <concept code="836385002" codeSystem="2.16.840.1.113883.6.96" displayName="Yellow fever virus antigen-containing vaccine product" level="0" type="L"/>
                <concept code="836387005" codeSystem="2.16.840.1.113883.6.96" displayName="Rotavirus antigen-containing vaccine product" level="0" type="L"/>
                <concept code="836388000" codeSystem="2.16.840.1.113883.6.96" displayName="Rubella virus antigen-containing vaccine product" level="0" type="L"/>
                <concept code="836389008" codeSystem="2.16.840.1.113883.6.96" displayName="Vaccinia virus antigen-containing vaccine product" level="0" type="L"/>
                <concept code="836390004" codeSystem="2.16.840.1.113883.6.96" displayName="Salmonella enterica subspecies enterica serovar Typhi antigen-containing vaccine product" level="0" type="L"/>
                <concept code="836393002" codeSystem="2.16.840.1.113883.6.96" displayName="Rabies lyssavirus antigen-containing vaccine product" level="0" type="L"/>
                <concept code="836397001" codeSystem="2.16.840.1.113883.6.96" displayName="Coxiella burnetii antigen-containing vaccine product" level="0" type="L"/>
                <concept code="836398006" codeSystem="2.16.840.1.113883.6.96" displayName="Streptococcus pneumoniae antigen-containing vaccine product" level="0" type="L"/>
                <concept code="836401009" codeSystem="2.16.840.1.113883.6.96" displayName="Neisseria meningitidis antigen-containing vaccine product" level="0" type="L"/>
                <concept code="836402002" codeSystem="2.16.840.1.113883.6.96" displayName="Bacillus Calmette-Guerin antigen-containing vaccine product" level="0" type="L"/>
                <concept code="836403007" codeSystem="2.16.840.1.113883.6.96" displayName="Tick-borne encephalitis virus antigen-containing vaccine product" level="0" type="L"/>
                <concept code="836495005" codeSystem="2.16.840.1.113883.6.96" displayName="Human alphaherpesvirus 3 antigen-containing vaccine product" level="0" type="L"/>
                <concept code="836498007" codeSystem="2.16.840.1.113883.6.96" displayName="Mumps orthorubulavirus antigen-containing vaccine product" level="0" type="L"/>
                <concept code="836500008" codeSystem="2.16.840.1.113883.6.96" displayName="Haemophilus influenzae type B and Neisseria meningitidis serogroup C antigens only vaccine product" level="0" type="L"/>
                <concept code="840549009" codeSystem="2.16.840.1.113883.6.96" displayName="Yersinia pestis antigen-containing vaccine product" level="0" type="L"/>
                <concept code="840563003" codeSystem="2.16.840.1.113883.6.96" displayName="Dengue virus antigen-containing vaccine product" level="0" type="L"/>
                <concept code="840599008" codeSystem="2.16.840.1.113883.6.96" displayName="Borrelia burgdorferi antigen-containing vaccine product" level="0" type="L"/>
                <concept code="863911006" codeSystem="2.16.840.1.113883.6.96" displayName="Clostridium tetani antigen-containing vaccine product" level="0" type="L"/>
                <concept code="871726005" codeSystem="2.16.840.1.113883.6.96" displayName="Rabies lyssavirus antigen only vaccine product" level="0" type="L"/>
                <concept code="871737006" codeSystem="2.16.840.1.113883.6.96" displayName="Mumps orthorubulavirus antigen only vaccine product" level="0" type="L"/>
                <concept code="871738001" codeSystem="2.16.840.1.113883.6.96" displayName="Live attenuated Mumps orthorubulavirus antigen only vaccine product" level="0" type="L"/>
                <concept code="871739009" codeSystem="2.16.840.1.113883.6.96" displayName="Human poliovirus antigen only vaccine product" level="0" type="L"/>
                <concept code="871740006" codeSystem="2.16.840.1.113883.6.96" displayName="Inactivated whole Human poliovirus antigen only vaccine product" level="0" type="L"/>
                <concept code="871742003" codeSystem="2.16.840.1.113883.6.96" displayName="Clostridium tetani antigen only vaccine product" level="0" type="L"/>
                <concept code="871751006" codeSystem="2.16.840.1.113883.6.96" displayName="Hepatitis A virus antigen only vaccine product" level="0" type="L"/>
                <concept code="871759008" codeSystem="2.16.840.1.113883.6.96" displayName="Acellular Bordetella pertussis only vaccine product" level="0" type="L"/>
                <concept code="871764007" codeSystem="2.16.840.1.113883.6.96" displayName="Haemophilus influenzae type b antigen only vaccine product" level="0" type="L"/>
                <concept code="871765008" codeSystem="2.16.840.1.113883.6.96" displayName="Measles morbillivirus antigen only vaccine product" level="0" type="L"/>
                <concept code="871768005" codeSystem="2.16.840.1.113883.6.96" displayName="Influenza virus antigen only vaccine product in nasal dose form" level="0" type="L"/>
                <concept code="871772009" codeSystem="2.16.840.1.113883.6.96" displayName="Influenza A virus subtype H1N1 antigen only vaccine product" level="0" type="L"/>
                <concept code="871803007" codeSystem="2.16.840.1.113883.6.96" displayName="Hepatitis A and Hepatitis B virus antigens only vaccine product" level="0" type="L"/>
                <concept code="871804001" codeSystem="2.16.840.1.113883.6.96" displayName="Hepatitis A virus and Salmonella enterica subspecies enterica serovar Typhi antigens only vaccine product" level="0" type="L"/>
                <concept code="871806004" codeSystem="2.16.840.1.113883.6.96" displayName="Haemophilus influenzae type B and Hepatitis B virus antigens only vaccine product" level="0" type="L"/>
                <concept code="871826000" codeSystem="2.16.840.1.113883.6.96" displayName="Clostridium tetani and Corynebacterium diphtheriae antigens only vaccine product" level="0" type="L"/>
                <concept code="871831003" codeSystem="2.16.840.1.113883.6.96" displayName="Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens only vaccine product" level="0" type="L"/>
                <concept code="871837004" codeSystem="2.16.840.1.113883.6.96" displayName="Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens only vaccine product" level="0" type="L"/>
                <concept code="871839001" codeSystem="2.16.840.1.113883.6.96" displayName="Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B antigens only vaccine product" level="0" type="L"/>
                <concept code="871866001" codeSystem="2.16.840.1.113883.6.96" displayName="Neisseria meningitidis serogroup C only vaccine product" level="0" type="L"/>
                <concept code="871871008" codeSystem="2.16.840.1.113883.6.96" displayName="Neisseria meningitidis serogroup A and C only vaccine product" level="0" type="L"/>
                <concept code="871873006" codeSystem="2.16.840.1.113883.6.96" displayName="Neisseria meningitidis serogroup A, C, W135 and Y only vaccine product" level="0" type="L"/>
                <concept code="871875004" codeSystem="2.16.840.1.113883.6.96" displayName="Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens only vaccine product" level="0" type="L"/>
                <concept code="871876003" codeSystem="2.16.840.1.113883.6.96" displayName="Acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens only vaccine product" level="0" type="L"/>
                <concept code="871878002" codeSystem="2.16.840.1.113883.6.96" displayName="Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens only vaccine product" level="0" type="L"/>
                <concept code="871887006" codeSystem="2.16.840.1.113883.6.96" displayName="Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Human poliovirus antigens only vaccine product" level="0" type="L"/>
                <concept code="871889009" codeSystem="2.16.840.1.113883.6.96" displayName="Acellular Bordetella pertussis and Corynebacterium diphtheriae and Hepatitis B virus and inactivated whole Human poliovirus antigens only vaccine product" level="0" type="L"/>
                <concept code="871895005" codeSystem="2.16.840.1.113883.6.96" displayName="Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus and Human poliovirus antigens only vaccine product" level="0" type="L"/>
                <concept code="871908002" codeSystem="2.16.840.1.113883.6.96" displayName="Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens only vaccine product" level="0" type="L"/>
                <concept code="871918007" codeSystem="2.16.840.1.113883.6.96" displayName="Rickettsia antigen-containing vaccine product" level="0" type="L"/>
                <concept code="871921009" codeSystem="2.16.840.1.113883.6.96" displayName="Staphylococcus toxoid vaccine" level="0" type="L"/>
                <concept code="921000221108" codeSystem="2.16.840.1.113883.6.96" displayName="Neisseria meningitidis antigen only vaccine product" level="0" type="L"/>
                <concept code="971000221109" codeSystem="2.16.840.1.113883.6.96" displayName="Live attenuated Salmonella enterica subspecies enterica serovar Typhi antigen only vaccine product in oral dose form" level="0" type="L"/>
                <concept code="981000221107" codeSystem="2.16.840.1.113883.6.96" displayName="Streptococcus pneumoniae antigen only vaccine product" level="0" type="L"/>
            </conceptList>
        </valueSet>
        <valueSet id="2.16.840.1.113883.3.1937.99.60.14.11.6" name="eHDSIVaccinesatc" displayName="eHDSIVaccines (ATC)" effectiveDate="2025-02-17T15:33:02" statusCode="draft">
            <desc language="en-US" lastTranslated="2025-04-04T13:23:33">
                <p>eHDSIVaccines (ATC)</p>
                <p style="color: orange">For testing and demo puposes only</p>
            </desc>
            <publishingAuthority name="eHDSI">
                <addrLine>eHealth Digital Service Infrastructure (eHDSI or eHealth DSI) </addrLine>
            </publishingAuthority>
            <conceptList>
                <concept code="J07AC" codeSystem="2.16.840.1.113883.6.73" displayName="Anthrax vaccines" level="0" type="L"/>
                <concept code="J07AC01" codeSystem="2.16.840.1.113883.6.73" displayName="anthrax antigen" level="0" type="L"/>
                <concept code="J07AD" codeSystem="2.16.840.1.113883.6.73" displayName="Brucellosis vaccines" level="0" type="L"/>
                <concept code="J07AD01" codeSystem="2.16.840.1.113883.6.73" displayName="brucella antigen" level="0" type="L"/>
                <concept code="J07AE" codeSystem="2.16.840.1.113883.6.73" displayName="Cholera vaccines" level="0" type="L"/>
                <concept code="J07AE01" codeSystem="2.16.840.1.113883.6.73" displayName="cholera, inactivated, whole cell" level="0" type="L"/>
                <concept code="J07AE02" codeSystem="2.16.840.1.113883.6.73" displayName="cholera, live attenuated" level="0" type="L"/>
                <concept code="J07AE51" codeSystem="2.16.840.1.113883.6.73" displayName="cholera, combinations with typhoid vaccine, inactivated, whole cell" level="0" type="L"/>
                <concept code="J07AF" codeSystem="2.16.840.1.113883.6.73" displayName="Diphtheria vaccines" level="0" type="L"/>
                <concept code="J07AF01" codeSystem="2.16.840.1.113883.6.73" displayName="diphtheria toxoid" level="0" type="L"/>
                <concept code="J07AG" codeSystem="2.16.840.1.113883.6.73" displayName="Haemophilus influenzae B vaccines" level="0" type="L"/>
                <concept code="J07AG01" codeSystem="2.16.840.1.113883.6.73" displayName="haemophilus influenzae B, purified antigen conjugated" level="0" type="L"/>
                <concept code="J07AG51" codeSystem="2.16.840.1.113883.6.73" displayName="haemophilus influenzae B, combinations with toxoids" level="0" type="L"/>
                <concept code="J07AG52" codeSystem="2.16.840.1.113883.6.73" displayName="haemophilus influenzae B, combinations with pertussis and toxoids" level="0" type="L"/>
                <concept code="J07AG53" codeSystem="2.16.840.1.113883.6.73" displayName="haemophilus influenzae B, combinations with meningococcus C, conjugated" level="0" type="L"/>
                <concept code="J07AG54" codeSystem="2.16.840.1.113883.6.73" displayName="haemophilus influenza B, combinations with meningococcus C,Y, conjugated" level="0" type="L"/>
                <concept code="J07AH" codeSystem="2.16.840.1.113883.6.73" displayName="Meningococcal vaccines" level="0" type="L"/>
                <concept code="J07AH01" codeSystem="2.16.840.1.113883.6.73" displayName="meningococcus A, purified polysaccharides antigen" level="0" type="L"/>
                <concept code="J07AH02" codeSystem="2.16.840.1.113883.6.73" displayName="other meningococcal monovalent purified polysaccharides antigen" level="0" type="L"/>
                <concept code="J07AH03" codeSystem="2.16.840.1.113883.6.73" displayName="meningococcus A,C, bivalent purified polysaccharides antigen" level="0" type="L"/>
                <concept code="J07AH04" codeSystem="2.16.840.1.113883.6.73" displayName="meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen" level="0" type="L"/>
                <concept code="J07AH05" codeSystem="2.16.840.1.113883.6.73" displayName="other meningococcal polyvalent purified polysaccharides antigen" level="0" type="L"/>
                <concept code="J07AH06" codeSystem="2.16.840.1.113883.6.73" displayName="meningococcus B, outer membrane vesicle vaccine" level="0" type="L"/>
                <concept code="J07AH07" codeSystem="2.16.840.1.113883.6.73" displayName="meningococcus C, purified polysaccharides antigen conjugated" level="0" type="L"/>
                <concept code="J07AH08" codeSystem="2.16.840.1.113883.6.73" displayName="meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated" level="0" type="L"/>
                <concept code="J07AH09" codeSystem="2.16.840.1.113883.6.73" displayName="meningococcus B, multicomponent vaccine" level="0" type="L"/>
                <concept code="J07AH10" codeSystem="2.16.840.1.113883.6.73" displayName="meningococcus A, purified polysaccharides antigen conjugated" level="0" type="L"/>
                <concept code="J07AH11" codeSystem="2.16.840.1.113883.6.73" displayName="meningococcus A,B,C,Y,W-135, pentavalent purified polysaccharides antigen conjugated and factor H binding protein" level="0" type="L"/>
                <concept code="J07AJ" codeSystem="2.16.840.1.113883.6.73" displayName="Pertussis vaccines" level="0" type="L"/>
                <concept code="J07AJ01" codeSystem="2.16.840.1.113883.6.73" displayName="pertussis, inactivated, whole cell" level="0" type="L"/>
                <concept code="J07AJ02" codeSystem="2.16.840.1.113883.6.73" displayName="pertussis, purified antigen" level="0" type="L"/>
                <concept code="J07AJ51" codeSystem="2.16.840.1.113883.6.73" displayName="pertussis, inactivated, whole cell, combinations with toxoids" level="0" type="L"/>
                <concept code="J07AJ52" codeSystem="2.16.840.1.113883.6.73" displayName="pertussis, purified antigen, combinations with toxoids" level="0" type="L"/>
                <concept code="J07AK" codeSystem="2.16.840.1.113883.6.73" displayName="Plague vaccines" level="0" type="L"/>
                <concept code="J07AK01" codeSystem="2.16.840.1.113883.6.73" displayName="plague, inactivated, whole cell" level="0" type="L"/>
                <concept code="J07AL" codeSystem="2.16.840.1.113883.6.73" displayName="Pneumococcal vaccines" level="0" type="L"/>
                <concept code="J07AL01" codeSystem="2.16.840.1.113883.6.73" displayName="pneumococcus, purified polysaccharides antigen" level="0" type="L"/>
                <concept code="J07AL02" codeSystem="2.16.840.1.113883.6.73" displayName="pneumococcus, purified polysaccharides antigen conjugated" level="0" type="L"/>
                <concept code="J07AL52" codeSystem="2.16.840.1.113883.6.73" displayName="pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated" level="0" type="L"/>
                <concept code="J07AM" codeSystem="2.16.840.1.113883.6.73" displayName="Tetanus vaccines" level="0" type="L"/>
                <concept code="J07AM01" codeSystem="2.16.840.1.113883.6.73" displayName="tetanus toxoid" level="0" type="L"/>
                <concept code="J07AM51" codeSystem="2.16.840.1.113883.6.73" displayName="tetanus toxoid, combinations with diphtheria toxoid" level="0" type="L"/>
                <concept code="J07AM52" codeSystem="2.16.840.1.113883.6.73" displayName="tetanus toxoid, combinations with tetanus immunoglobulin" level="0" type="L"/>
                <concept code="J07AN" codeSystem="2.16.840.1.113883.6.73" displayName="Tuberculosis vaccines" level="0" type="L"/>
                <concept code="J07AN01" codeSystem="2.16.840.1.113883.6.73" displayName="tuberculosis, live attenuated" level="0" type="L"/>
                <concept code="J07AP" codeSystem="2.16.840.1.113883.6.73" displayName="Typhoid vaccines" level="0" type="L"/>
                <concept code="J07AP01" codeSystem="2.16.840.1.113883.6.73" displayName="typhoid, oral, live attenuated" level="0" type="L"/>
                <concept code="J07AP02" codeSystem="2.16.840.1.113883.6.73" displayName="typhoid, inactivated, whole cell" level="0" type="L"/>
                <concept code="J07AP03" codeSystem="2.16.840.1.113883.6.73" displayName="typhoid, purified polysaccharide antigen" level="0" type="L"/>
                <concept code="J07AP10" codeSystem="2.16.840.1.113883.6.73" displayName="typhoid, combinations with paratyphi types" level="0" type="L"/>
                <concept code="J07AR" codeSystem="2.16.840.1.113883.6.73" displayName="Typhus (exanthematicus) vaccines" level="0" type="L"/>
                <concept code="J07AR01" codeSystem="2.16.840.1.113883.6.73" displayName="typhus exanthematicus, inactivated, whole cell" level="0" type="L"/>
                <concept code="J07AX" codeSystem="2.16.840.1.113883.6.73" displayName="Other bacterial vaccines" level="0" type="L"/>
                <concept code="J07AX01" codeSystem="2.16.840.1.113883.6.73" displayName="leptospira vaccines" level="0" type="L"/>
                <concept code="J07BA" codeSystem="2.16.840.1.113883.6.73" displayName="Encephalitis vaccines" level="0" type="L"/>
                <concept code="J07BA01" codeSystem="2.16.840.1.113883.6.73" displayName="encephalitis, tick borne, inactivated, whole virus" level="0" type="L"/>
                <concept code="J07BA02" codeSystem="2.16.840.1.113883.6.73" displayName="encephalitis, Japanese, inactivated, whole virus" level="0" type="L"/>
                <concept code="J07BA03" codeSystem="2.16.840.1.113883.6.73" displayName="encephalitis, Japanese, live attenuated" level="0" type="L"/>
                <concept code="J07BB" codeSystem="2.16.840.1.113883.6.73" displayName="Influenza vaccines" level="0" type="L"/>
                <concept code="J07BB01" codeSystem="2.16.840.1.113883.6.73" displayName="influenza, inactivated, whole virus" level="0" type="L"/>
                <concept code="J07BB02" codeSystem="2.16.840.1.113883.6.73" displayName="influenza, inactivated, split virus or surface antigen" level="0" type="L"/>
                <concept code="J07BB03" codeSystem="2.16.840.1.113883.6.73" displayName="influenza, live attenuated" level="0" type="L"/>
                <concept code="J07BB04" codeSystem="2.16.840.1.113883.6.73" displayName="influenza, virus like particles" level="0" type="L"/>
                <concept code="J07BB05" codeSystem="2.16.840.1.113883.6.73" displayName="influenza, RNA-based vaccine" level="0" type="L"/>
                <concept code="J07BC" codeSystem="2.16.840.1.113883.6.73" displayName="Hepatitis vaccines" level="0" type="L"/>
                <concept code="J07BC01" codeSystem="2.16.840.1.113883.6.73" displayName="hepatitis B, purified antigen" level="0" type="L"/>
                <concept code="J07BC02" codeSystem="2.16.840.1.113883.6.73" displayName="hepatitis A, inactivated, whole virus" level="0" type="L"/>
                <concept code="J07BC20" codeSystem="2.16.840.1.113883.6.73" displayName="combinations" level="0" type="L"/>
                <concept code="J07BD" codeSystem="2.16.840.1.113883.6.73" displayName="Measles vaccines" level="0" type="L"/>
                <concept code="J07BD01" codeSystem="2.16.840.1.113883.6.73" displayName="measles, live attenuated" level="0" type="L"/>
                <concept code="J07BD51" codeSystem="2.16.840.1.113883.6.73" displayName="measles, combinations with mumps, live attenuated" level="0" type="L"/>
                <concept code="J07BD52" codeSystem="2.16.840.1.113883.6.73" displayName="measles, combinations with mumps and rubella, live attenuated" level="0" type="L"/>
                <concept code="J07BD53" codeSystem="2.16.840.1.113883.6.73" displayName="measles, combinations with rubella, live attenuated" level="0" type="L"/>
                <concept code="J07BD54" codeSystem="2.16.840.1.113883.6.73" displayName="measles, combinations with mumps, rubella and varicella, live attenuated" level="0" type="L"/>
                <concept code="J07BE" codeSystem="2.16.840.1.113883.6.73" displayName="Mumps vaccines" level="0" type="L"/>
                <concept code="J07BE01" codeSystem="2.16.840.1.113883.6.73" displayName="mumps, live attenuated" level="0" type="L"/>
                <concept code="J07BF" codeSystem="2.16.840.1.113883.6.73" displayName="Poliomyelitis vaccines" level="0" type="L"/>
                <concept code="J07BF01" codeSystem="2.16.840.1.113883.6.73" displayName="poliomyelitis oral, monovalent, live attenuated" level="0" type="L"/>
                <concept code="J07BF02" codeSystem="2.16.840.1.113883.6.73" displayName="poliomyelitis oral, trivalent, live attenuated" level="0" type="L"/>
                <concept code="J07BF03" codeSystem="2.16.840.1.113883.6.73" displayName="poliomyelitis, trivalent, inactivated, whole virus" level="0" type="L"/>
                <concept code="J07BF04" codeSystem="2.16.840.1.113883.6.73" displayName="poliomyelitis oral, bivalent, live attenuated" level="0" type="L"/>
                <concept code="J07BG" codeSystem="2.16.840.1.113883.6.73" displayName="Rabies vaccines" level="0" type="L"/>
                <concept code="J07BG01" codeSystem="2.16.840.1.113883.6.73" displayName="rabies, inactivated, whole virus" level="0" type="L"/>
                <concept code="J07BH" codeSystem="2.16.840.1.113883.6.73" displayName="Rota virus diarrhea vaccines" level="0" type="L"/>
                <concept code="J07BH01" codeSystem="2.16.840.1.113883.6.73" displayName="rota virus, live attenuated" level="0" type="L"/>
                <concept code="J07BH02" codeSystem="2.16.840.1.113883.6.73" displayName="rota virus, pentavalent, live, reassorted" level="0" type="L"/>
                <concept code="J07BJ" codeSystem="2.16.840.1.113883.6.73" displayName="Rubella vaccines" level="0" type="L"/>
                <concept code="J07BJ01" codeSystem="2.16.840.1.113883.6.73" displayName="rubella, live attenuated" level="0" type="L"/>
                <concept code="J07BJ51" codeSystem="2.16.840.1.113883.6.73" displayName="rubella, combinations with mumps, live attenuated" level="0" type="L"/>
                <concept code="J07BK" codeSystem="2.16.840.1.113883.6.73" displayName="Varicella zoster vaccines" level="0" type="L"/>
                <concept code="J07BK01" codeSystem="2.16.840.1.113883.6.73" displayName="varicella, live attenuated" level="0" type="L"/>
                <concept code="J07BK02" codeSystem="2.16.840.1.113883.6.73" displayName="zoster, live attenuated" level="0" type="L"/>
                <concept code="J07BK03" codeSystem="2.16.840.1.113883.6.73" displayName="zoster, purified antigen" level="0" type="L"/>
                <concept code="J07BL" codeSystem="2.16.840.1.113883.6.73" displayName="Yellow fever vaccines" level="0" type="L"/>
                <concept code="J07BL01" codeSystem="2.16.840.1.113883.6.73" displayName="yellow fever, live attenuated" level="0" type="L"/>
                <concept code="J07BM" codeSystem="2.16.840.1.113883.6.73" displayName="Papillomavirus vaccines" level="0" type="L"/>
                <concept code="J07BM01" codeSystem="2.16.840.1.113883.6.73" displayName="papillomavirus (human types 6, 11, 16, 18)" level="0" type="L"/>
                <concept code="J07BM02" codeSystem="2.16.840.1.113883.6.73" displayName="papillomavirus (human types 16, 18)" level="0" type="L"/>
                <concept code="J07BM03" codeSystem="2.16.840.1.113883.6.73" displayName="papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)" level="0" type="L"/>
                <concept code="J07BN" codeSystem="2.16.840.1.113883.6.73" displayName="Covid-19 vaccines" level="0" type="L"/>
                <concept code="J07BN01" codeSystem="2.16.840.1.113883.6.73" displayName="covid-19, RNA-based vaccine" level="0" type="L"/>
                <concept code="J07BN02" codeSystem="2.16.840.1.113883.6.73" displayName="covid-19, viral vector, non-replicating" level="0" type="L"/>
                <concept code="J07BN03" codeSystem="2.16.840.1.113883.6.73" displayName="covid-19, inactivated virus" level="0" type="L"/>
                <concept code="J07BN04" codeSystem="2.16.840.1.113883.6.73" displayName="covid-19, protein subunit" level="0" type="L"/>
                <concept code="J07BN05" codeSystem="2.16.840.1.113883.6.73" displayName="covid-19, virus-like particles" level="0" type="L"/>
                <concept code="J07BX" codeSystem="2.16.840.1.113883.6.73" displayName="Other viral vaccines" level="0" type="L"/>
                <concept code="J07BX01" codeSystem="2.16.840.1.113883.6.73" displayName="smallpox and monkeypox vaccines" level="0" type="L"/>
                <concept code="J07BX02" codeSystem="2.16.840.1.113883.6.73" displayName="ebola vaccines" level="0" type="L"/>
                <concept code="J07BX04" codeSystem="2.16.840.1.113883.6.73" displayName="dengue virus vaccines" level="0" type="L"/>
                <concept code="J07BX05" codeSystem="2.16.840.1.113883.6.73" displayName="respiratory syncytial virus vaccines" level="0" type="L"/>
                <concept code="J07BX06" codeSystem="2.16.840.1.113883.6.73" displayName="enterovirus 71 vaccines" level="0" type="L"/>
                <concept code="J07CA" codeSystem="2.16.840.1.113883.6.73" displayName="Bacterial and viral vaccines, combined" level="0" type="L"/>
                <concept code="J07CA01" codeSystem="2.16.840.1.113883.6.73" displayName="diphtheria-poliomyelitis-tetanus" level="0" type="L"/>
                <concept code="J07CA02" codeSystem="2.16.840.1.113883.6.73" displayName="diphtheria-pertussis-poliomyelitis-tetanus" level="0" type="L"/>
                <concept code="J07CA03" codeSystem="2.16.840.1.113883.6.73" displayName="diphtheria-rubella-tetanus" level="0" type="L"/>
                <concept code="J07CA04" codeSystem="2.16.840.1.113883.6.73" displayName="haemophilus influenzae B and poliomyelitis" level="0" type="L"/>
                <concept code="J07CA05" codeSystem="2.16.840.1.113883.6.73" displayName="diphtheria-hepatitis B-pertussis-tetanus" level="0" type="L"/>
                <concept code="J07CA06" codeSystem="2.16.840.1.113883.6.73" displayName="diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus" level="0" type="L"/>
                <concept code="J07CA07" codeSystem="2.16.840.1.113883.6.73" displayName="diphtheria-hepatitis B-tetanus" level="0" type="L"/>
                <concept code="J07CA08" codeSystem="2.16.840.1.113883.6.73" displayName="haemophilus influenzae B and hepatitis B" level="0" type="L"/>
                <concept code="J07CA09" codeSystem="2.16.840.1.113883.6.73" displayName="diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B" level="0" type="L"/>
                <concept code="J07CA10" codeSystem="2.16.840.1.113883.6.73" displayName="typhoid-hepatitis A" level="0" type="L"/>
                <concept code="J07CA11" codeSystem="2.16.840.1.113883.6.73" displayName="diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B" level="0" type="L"/>
                <concept code="J07CA12" codeSystem="2.16.840.1.113883.6.73" displayName="diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B" level="0" type="L"/>
                <concept code="J07CA13" codeSystem="2.16.840.1.113883.6.73" displayName="diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C" level="0" type="L"/>
                <concept code="J07XA" codeSystem="2.16.840.1.113883.6.73" displayName="Parasitic vaccines" level="0" type="L"/>
                <concept code="J07XA01" codeSystem="2.16.840.1.113883.6.73" displayName="malaria vaccines" level="0" type="L"/>
            </conceptList>
        </valueSet>
        <valueSet id="2.16.840.1.113883.3.1937.99.60.14.11.7" name="CVx2" displayName="Subset Vaccine Administered Code Set (CVX)" effectiveDate="2025-04-26T00:00:00" statusCode="draft">
            <desc language="en-US" lastTranslated="2025-04-04T13:23:33">
                <p>Vaccine Administered Code Set (CVX) System: http://hl7.org/fhir/sid/cvx</p>
            </desc>
            <conceptList>
                <concept code="10" codeSystem="2.16.840.1.113883.12.292" displayName="poliovirus vaccine, inactivated" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="IPV"/>
                </concept>
                <concept code="113" codeSystem="2.16.840.1.113883.12.292" displayName="tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed"/>
                </concept>
                <concept code="114" codeSystem="2.16.840.1.113883.12.292" displayName="meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P)" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="meningococcal MCV4P"/>
                </concept>
                <concept code="115" codeSystem="2.16.840.1.113883.12.292" displayName="tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Tdap"/>
                </concept>
                <concept code="119" codeSystem="2.16.840.1.113883.12.292" displayName="rotavirus, live, monovalent vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="rotavirus, monovalent"/>
                </concept>
                <concept code="121" codeSystem="2.16.840.1.113883.12.292" displayName="zoster vaccine, live" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="zoster live"/>
                </concept>
                <concept code="133" codeSystem="2.16.840.1.113883.12.292" displayName="pneumococcal conjugate vaccine, 13 valent" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Pneumococcal conjugate PCV 13"/>
                </concept>
                <concept code="140" codeSystem="2.16.840.1.113883.12.292" displayName="Influenza, seasonal, injectable, preservative free" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Influenza, seasonal, injectable, preservative free"/>
                </concept>
                <concept code="20" codeSystem="2.16.840.1.113883.12.292" displayName="diphtheria, tetanus toxoids and acellular pertussis vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="DTaP"/>
                </concept>
                <concept code="207" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose"/>
                </concept>
                <concept code="208" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose"/>
                </concept>
                <concept code="21" codeSystem="2.16.840.1.113883.12.292" displayName="varicella virus vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="varicella"/>
                </concept>
                <concept code="212" codeSystem="2.16.840.1.113883.12.292" displayName="SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL"/>
                </concept>
                <concept code="3" codeSystem="2.16.840.1.113883.12.292" displayName="measles, mumps and rubella virus vaccine" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="MMR"/>
                </concept>
                <concept code="33" codeSystem="2.16.840.1.113883.12.292" displayName="pneumococcal polysaccharide vaccine, 23 valent" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="pneumococcal polysaccharide PPV23"/>
                </concept>
                <concept code="43" codeSystem="2.16.840.1.113883.12.292" displayName="hepatitis B vaccine, adult dosage" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hep B, adult"/>
                </concept>
                <concept code="49" codeSystem="2.16.840.1.113883.12.292" displayName="Haemophilus influenzae type b vaccine, PRP-OMP conjugate" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hib (PRP-OMP)"/>
                </concept>
                <concept code="52" codeSystem="2.16.840.1.113883.12.292" displayName="hepatitis A vaccine, adult dosage" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hep A, adult"/>
                </concept>
                <concept code="62" codeSystem="2.16.840.1.113883.12.292" displayName="human papilloma virus vaccine, quadrivalent" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="HPV, quadrivalent"/>
                </concept>
                <concept code="8" codeSystem="2.16.840.1.113883.12.292" displayName="hepatitis B vaccine, pediatric or pediatric/adolescent dosage" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hep B, adolescent or pediatric"/>
                </concept>
                <concept code="83" codeSystem="2.16.840.1.113883.12.292" displayName="hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule" level="0" type="L">
                    <designation language="en-US" type="synonym" displayName="Hep A, ped/adol, 2 dose"/>
                </concept>
            </conceptList>
        </valueSet>
        <conceptMap id="2.16.840.1.113883.3.1937.99.60.14.24.1" displayName="Cvx Group to SNOMED-CT Vaccine Products" effectiveDate="2025-04-26T11:35:43" statusCode="draft" lastModifiedDate="2025-04-26T16:28:23">
            <sourceScope ref="2.16.840.1.113883.3.1937.99.60.14.11.7" flexibility="2025-04-26T00:00:00" displayName="Subset Vaccine Administered Code Set (CVX)"/>
            <targetScope ref="2.16.840.1.113883.3.1937.99.60.14.11.4" flexibility="2025-04-26T11:29:30" displayName="Vaccine Product Expansion Set (SNOMED-CT)"/>
            <group>
                <source codeSystem="2.16.840.1.113883.12.292" displayName="Vaccine Administered" canonicalUri="http://hl7.org/fhir/sid/cvx"/>
                <target codeSystem="2.16.840.1.113883.6.96" displayName="SNOMED Clinical Terms" canonicalUri="http://snomed.info/sct"/>
                <element code="208" displayName="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose">
                    <target code="1119349007" relationship="equivalent" displayName="Vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (medicinal product)"/>
                </element>
                <element code="10" displayName="poliovirus vaccine, inactivated">
                    <target code="871740006" relationship="equivalent" displayName="Vaccine product containing only inactivated whole Human poliovirus antigen (medicinal product)"/>
                </element>
                <element code="113" displayName="tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)">
                    <target code="777725002" relationship="equivalent" displayName="Vaccine product containing only Clostridium tetani toxoid antigen adsorbed (medicinal product)"/>
                </element>
                <element code="114" displayName="meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P)">
                    <target code="836401009" relationship="equivalent" displayName="Vaccine product containing Neisseria meningitidis antigen (medicinal product)"/>
                </element>
                <element code="115" displayName="tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed">
                    <target code="871875004" relationship="equivalent" displayName="Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens (medicinal product)"/>
                </element>
                <element code="119" displayName="rotavirus, live, monovalent vaccine">
                    <target code="871761004" relationship="equivalent" displayName="Vaccine product containing only Rotavirus antigen (medicinal product)"/>
                </element>
                <element code="121" displayName="zoster vaccine, live">
                    <target code="2221000221107" relationship="equivalent" displayName="Vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen (medicinal product)"/>
                </element>
                <element code="133" displayName="pneumococcal conjugate vaccine, 13 valent">
                    <target code="51451000087105" relationship="equivalent" displayName="Vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens conjugated (medicinal product)"/>
                </element>
                <element code="140" displayName="Influenza, seasonal, injectable, preservative free">
                    <target code="1181000221105" relationship="equivalent" displayName="Vaccine product containing only Influenza virus antigen (medicinal product)"/>
                </element>
                <element code="20" displayName="diphtheria, tetanus toxoids and acellular pertussis vaccine">
                    <target code="871875004" relationship="equivalent" displayName="Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens (medicinal product)"/>
                </element>
                <element code="207" displayName="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose">
                    <target code="1119349007" relationship="equivalent" displayName="Vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (medicinal product)"/>
                </element>
                <element code="21" displayName="varicella virus vaccine">
                    <target code="871919004" relationship="equivalent" displayName="Vaccine product containing only Human alphaherpesvirus 3 antigen (medicinal product)"/>
                </element>
                <element code="212" displayName="SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL">
                    <target code="29061000087103" relationship="equivalent" displayName="Vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (medicinal product)"/>
                </element>
                <element code="3" displayName="measles, mumps and rubella virus vaccine">
                    <target code="871831003" relationship="equivalent" displayName="Vaccine product containing only Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (medicinal product)"/>
                </element>
                <element code="33" displayName="pneumococcal polysaccharide vaccine, 23 valent">
                    <target code="1252709000" relationship="equivalent" displayName="Vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, 33F capsular polysaccharide antigens conjugated (medicinal product)"/>
                </element>
                <element code="43" displayName="hepatitis B vaccine, adult dosage">
                    <target code="871822003" relationship="equivalent" displayName="Vaccine product containing only Hepatitis B virus antigen (medicinal product)"/>
                </element>
                <element code="49" displayName="Haemophilus influenzae type b vaccine, PRP-OMP conjugate">
                    <target code="871764007" relationship="equivalent" displayName="Vaccine product containing only Haemophilus influenzae type b antigen (medicinal product)"/>
                </element>
                <element code="52" displayName="hepatitis A vaccine, adult dosage">
                    <target code="871751006" relationship="equivalent" displayName="Vaccine product containing only Hepatitis A virus antigen (medicinal product)"/>
                </element>
                <element code="62" displayName="human papilloma virus vaccine, quadrivalent">
                    <target code="2001000221108" relationship="equivalent" displayName="Vaccine product containing only Human papillomavirus 6, 11, 16 and 18 antigens (medicinal product)"/>
                </element>
                <element code="8" displayName="hepatitis B vaccine, pediatric or pediatric/adolescent dosage">
                    <target code="871822003" relationship="equivalent" displayName="Vaccine product containing only Hepatitis B virus antigen (medicinal product)"/>
                </element>
                <element code="83" displayName="hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule">
                    <target code="871751006" relationship="equivalent" displayName="Vaccine product containing only Hepatitis A virus antigen (medicinal product)"/>
                </element>
            </group>
        </conceptMap>
    </terminology>
    <rules/>
    <issues/>
</decor>
